US20030161889A1
(en)
*
|
1984-03-16 |
2003-08-28 |
Reid Robert H. |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
US5693343A
(en)
|
1984-03-16 |
1997-12-02 |
The United States Of America As Represented By The Secretary Of The Army |
Microparticle carriers of maximal uptake capacity by both M cells and non-M cells
|
US6309669B1
(en)
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
USRE40786E1
(en)
|
1984-03-16 |
2009-06-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
|
US6410056B1
(en)
|
1984-03-16 |
2002-06-25 |
The United States Of America As Represented By The Secretary Of The Army |
Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
|
US6217911B1
(en)
|
1995-05-22 |
2001-04-17 |
The United States Of America As Represented By The Secretary Of The Army |
sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
|
US5904717A
(en)
*
|
1986-01-28 |
1999-05-18 |
Thm Biomedical, Inc. |
Method and device for reconstruction of articular cartilage
|
US5843156A
(en)
*
|
1988-08-24 |
1998-12-01 |
Endoluminal Therapeutics, Inc. |
Local polymeric gel cellular therapy
|
US5575815A
(en)
*
|
1988-08-24 |
1996-11-19 |
Endoluminal Therapeutics, Inc. |
Local polymeric gel therapy
|
US5634946A
(en)
*
|
1988-08-24 |
1997-06-03 |
Focal, Inc. |
Polymeric endoluminal paving process
|
DE68922497T2
(de)
*
|
1988-08-24 |
1995-09-14 |
Marvin J Slepian |
Endoluminale dichtung mit bisdegradierbaren polymeren.
|
US4938763B1
(en)
*
|
1988-10-03 |
1995-07-04 |
Atrix Lab Inc |
Biodegradable in-situ forming implants and method of producing the same
|
US5725491A
(en)
*
|
1988-10-03 |
1998-03-10 |
Atrix Laboratories, Inc. |
Method of forming a biodegradable film dressing on tissue
|
US5632727A
(en)
*
|
1988-10-03 |
1997-05-27 |
Atrix Laboratories, Inc. |
Biodegradable film dressing and method for its formation
|
US5702716A
(en)
*
|
1988-10-03 |
1997-12-30 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
US5324519A
(en)
*
|
1989-07-24 |
1994-06-28 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
US5077049A
(en)
*
|
1989-07-24 |
1991-12-31 |
Vipont Pharmaceutical, Inc. |
Biodegradable system for regenerating the periodontium
|
US5487897A
(en)
*
|
1989-07-24 |
1996-01-30 |
Atrix Laboratories, Inc. |
Biodegradable implant precursor
|
US5525348A
(en)
*
|
1989-11-02 |
1996-06-11 |
Sts Biopolymers, Inc. |
Coating compositions comprising pharmaceutical agents
|
USRE37950E1
(en)
|
1990-04-24 |
2002-12-31 |
Atrix Laboratories |
Biogradable in-situ forming implants and methods of producing the same
|
NL9001428A
(nl)
*
|
1990-06-21 |
1992-01-16 |
Stichting Tech Wetenschapp |
Microporeuze buisvormige prothesen.
|
US5269785A
(en)
*
|
1990-06-28 |
1993-12-14 |
Bonutti Peter M |
Apparatus and method for tissue removal
|
EP0489743A1
(de)
*
|
1990-07-03 |
1992-06-17 |
Vipont Pharmaceutical, Inc. |
Intragingivale vorrichtung zur verabreichung von wirkstoffen zur behandlung paradontaler krankheiten
|
DE69129812T2
(de)
*
|
1990-07-12 |
1999-02-11 |
Sts Biopolymers Inc |
Antithrombogene und/oder antimikrobielle zusammensetzung
|
US5462990A
(en)
*
|
1990-10-15 |
1995-10-31 |
Board Of Regents, The University Of Texas System |
Multifunctional organic polymers
|
US5626863A
(en)
*
|
1992-02-28 |
1997-05-06 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
US5410016A
(en)
*
|
1990-10-15 |
1995-04-25 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
US5620700A
(en)
*
|
1990-10-30 |
1997-04-15 |
Alza Corporation |
Injectable drug delivery system and method
|
AU8303691A
(en)
|
1991-04-24 |
1992-12-21 |
United States Of America, As Represented By The Secretary Of The Army, The |
Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
US6503277B2
(en)
*
|
1991-08-12 |
2003-01-07 |
Peter M. Bonutti |
Method of transplanting human body tissue
|
AU2605592A
(en)
|
1991-10-15 |
1993-04-22 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
US5270047A
(en)
*
|
1991-11-21 |
1993-12-14 |
Kauffman Raymond F |
Local delivery of dipyridamole for the treatment of proliferative diseases
|
WO1993015787A1
(en)
*
|
1992-02-12 |
1993-08-19 |
Chandler Jerry W |
Biodegradable stent
|
US5573934A
(en)
*
|
1992-04-20 |
1996-11-12 |
Board Of Regents, The University Of Texas System |
Gels for encapsulation of biological materials
|
CA2117588C
(en)
|
1992-02-28 |
1998-08-25 |
Jeffrey A. Hubbell |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
EP0560014A1
(de)
*
|
1992-03-12 |
1993-09-15 |
Atrix Laboratories, Inc. |
Biologisch abbaubarer Wundverband in Form eines Sprühfilms und Verfahren zu seiner Herstellung
|
US5384333A
(en)
*
|
1992-03-17 |
1995-01-24 |
University Of Miami |
Biodegradable injectable drug delivery polymer
|
US5540240A
(en)
*
|
1992-03-26 |
1996-07-30 |
Bauer; William |
Intranasal septal fastener driving method
|
US5370294A
(en)
*
|
1992-03-26 |
1994-12-06 |
Bauer; William |
Intranasal septal stapling device and method
|
FR2689400B1
(fr)
*
|
1992-04-03 |
1995-06-23 |
Inoteb |
Materiau pour prothese osseuse contenant des particules de carbonate de calcium dispersees dans une matrice polymere bioresorbable.
|
GB9211268D0
(en)
*
|
1992-05-28 |
1992-07-15 |
Ici Plc |
Salts of basic peptides with carboxyterminated polyesters
|
NZ247712A
(en)
*
|
1992-06-19 |
1995-04-27 |
Colgate Palmolive Co |
Oral composition comprising an anti-bacterial compound, a water-insoluble biodegradable polymer, and an organic solvent
|
US5242910A
(en)
†
|
1992-10-13 |
1993-09-07 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
US5910520A
(en)
*
|
1993-01-15 |
1999-06-08 |
Mcneil-Ppc, Inc. |
Melt processable biodegradable compositions and articles made therefrom
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5800373A
(en)
*
|
1995-03-23 |
1998-09-01 |
Focal, Inc. |
Initiator priming for improved adherence of gels to substrates
|
US5749968A
(en)
*
|
1993-03-01 |
1998-05-12 |
Focal, Inc. |
Device for priming for improved adherence of gels to substrates
|
US6004547A
(en)
|
1997-09-29 |
1999-12-21 |
Focal, Inc. |
Apparatus and method for local application of polymeric material to tissue
|
DE69414558T2
(de)
*
|
1993-03-23 |
1999-07-15 |
Focal Inc |
Gerät und methode für den lokalen auftrag von polymermaterial auf gewebe
|
US5321113A
(en)
*
|
1993-05-14 |
1994-06-14 |
Ethicon, Inc. |
Copolymers of an aromatic anhydride and aliphatic ester
|
US6939546B2
(en)
|
1993-05-21 |
2005-09-06 |
The United States Of America As Represented By The Secretary Of The Army |
Model for testing immunogenicity of peptides
|
CA2123647C
(en)
*
|
1993-06-11 |
2007-04-17 |
Steven L. Bennett |
Bioabsorbable copolymer and coating composition containing same
|
US5425949A
(en)
*
|
1993-06-11 |
1995-06-20 |
United States Surgical Corporation |
Bioabsorbable copolymer and coating composition containing same
|
US5925065A
(en)
*
|
1993-06-11 |
1999-07-20 |
United States Surgical Corporation |
Coated gut suture
|
CN100998869A
(zh)
|
1993-07-19 |
2007-07-18 |
血管技术药物公司 |
抗血管生长组合物及使用方法
|
JP3220331B2
(ja)
*
|
1993-07-20 |
2001-10-22 |
エチコン・インコーポレーテツド |
非経口投与用の吸収性液体コポリマー類
|
US6908910B2
(en)
*
|
1993-08-06 |
2005-06-21 |
The Children's Medical Center Corporation |
Estrogenic compounds as anti-mitotic agents
|
CA2128912A1
(en)
*
|
1993-08-17 |
1995-02-18 |
Zygmunt Teodorczyk |
Modified phenol-aldehyde resin and binder system
|
US5468855A
(en)
*
|
1993-09-09 |
1995-11-21 |
Ciba-Geigy Corporation |
Bislactones
|
US5681873A
(en)
*
|
1993-10-14 |
1997-10-28 |
Atrix Laboratories, Inc. |
Biodegradable polymeric composition
|
AU8095694A
(en)
*
|
1993-10-28 |
1995-05-22 |
Thm Biomedical, Inc. |
Improved process and device for treating and healing a bone void
|
FR2715309B1
(fr)
*
|
1994-01-24 |
1996-08-02 |
Imedex |
Composition adhésive, à usage chirurgical, à base de collagène modifié par coupure oxydative et non réticulé.
|
CA2140053C
(en)
*
|
1994-02-09 |
2000-04-04 |
Joel S. Rosenblatt |
Collagen-based injectable drug delivery system and its use
|
US5502092A
(en)
*
|
1994-02-18 |
1996-03-26 |
Minnesota Mining And Manufacturing Company |
Biocompatible porous matrix of bioabsorbable material
|
US6074840A
(en)
|
1994-02-18 |
2000-06-13 |
The Regents Of The University Of Michigan |
Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
|
US20020193338A1
(en)
*
|
1994-02-18 |
2002-12-19 |
Goldstein Steven A. |
In vivo gene transfer methods for wound healing
|
US5962427A
(en)
*
|
1994-02-18 |
1999-10-05 |
The Regent Of The University Of Michigan |
In vivo gene transfer methods for wound healing
|
US5942496A
(en)
*
|
1994-02-18 |
1999-08-24 |
The Regent Of The University Of Michigan |
Methods and compositions for multiple gene transfer into bone cells
|
US5763416A
(en)
*
|
1994-02-18 |
1998-06-09 |
The Regent Of The University Of Michigan |
Gene transfer into bone cells and tissues
|
US6551618B2
(en)
*
|
1994-03-15 |
2003-04-22 |
University Of Birmingham |
Compositions and methods for delivery of agents for neuronal regeneration and survival
|
JP4259610B2
(ja)
*
|
1994-04-08 |
2009-04-30 |
キューエルティー・ユーエスエイ・インコーポレーテッド |
液体デリバリー組成物
|
DE69530919T2
(de)
*
|
1994-04-08 |
2004-05-13 |
Atrix Laboratories, Inc., Fort Collins |
Beigeordnetes polymersystem zur verwendung mit einer medizinischen vorrichtung
|
US6140452A
(en)
*
|
1994-05-06 |
2000-10-31 |
Advanced Bio Surfaces, Inc. |
Biomaterial for in situ tissue repair
|
US20050043808A1
(en)
*
|
1994-05-06 |
2005-02-24 |
Advanced Bio Surfaces, Inc. |
Knee joint prosthesis
|
US5556429A
(en)
*
|
1994-05-06 |
1996-09-17 |
Advanced Bio Surfaces, Inc. |
Joint resurfacing system
|
US5981825A
(en)
|
1994-05-13 |
1999-11-09 |
Thm Biomedical, Inc. |
Device and methods for in vivo culturing of diverse tissue cells
|
US6855331B2
(en)
|
1994-05-16 |
2005-02-15 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US6447796B1
(en)
|
1994-05-16 |
2002-09-10 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
DK63894A
(da)
*
|
1994-06-06 |
1996-01-08 |
Meadox Medicals Inc |
Kateter med stent samt fremgangsmåde til fremstilling af et sådant kateter med stent
|
US5665063A
(en)
*
|
1994-06-24 |
1997-09-09 |
Focal, Inc. |
Methods for application of intraluminal photopolymerized gels
|
US5531735A
(en)
*
|
1994-09-27 |
1996-07-02 |
Hercules Incorporated |
Medical devices containing triggerable disintegration agents
|
AU1287895A
(en)
*
|
1994-10-03 |
1996-04-26 |
Otogen Corporation |
Differentially biodegradable biomedical implants
|
US5599852A
(en)
|
1994-10-18 |
1997-02-04 |
Ethicon, Inc. |
Injectable microdispersions for soft tissue repair and augmentation
|
AU706434B2
(en)
|
1994-10-18 |
1999-06-17 |
Ethicon Inc. |
Injectable liquid copolymers for soft tissue repair and augmentation
|
US6335383B1
(en)
|
1994-10-18 |
2002-01-01 |
Ethicon, Inc. |
Microdispersions for coating surgical devices
|
US5607686A
(en)
*
|
1994-11-22 |
1997-03-04 |
United States Surgical Corporation |
Polymeric composition
|
US5550172A
(en)
*
|
1995-02-07 |
1996-08-27 |
Ethicon, Inc. |
Utilization of biocompatible adhesive/sealant materials for securing surgical devices
|
ATE369402T1
(de)
|
1995-03-23 |
2007-08-15 |
Genzyme Corp |
Redox und photoinitiatorsystem zur grundierung von verbesserter adhäsion von gelen zu substraten
|
US5900245A
(en)
|
1996-03-22 |
1999-05-04 |
Focal, Inc. |
Compliant tissue sealants
|
JP3145409B2
(ja)
*
|
1995-03-24 |
2001-03-12 |
フォーカル, インコーポレイテッド |
活性酸素阻害剤の制御送達を用いる癒着の低減
|
US5612052A
(en)
*
|
1995-04-13 |
1997-03-18 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
US6551610B2
(en)
|
1995-04-13 |
2003-04-22 |
Poly-Med, Inc. |
Multifaceted compositions for post-surgical adhesion prevention
|
US6413539B1
(en)
|
1996-10-31 |
2002-07-02 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
AU5069796A
(en)
*
|
1995-04-28 |
1996-11-07 |
Ethicon Inc. |
Solventless tipping of braided surgical ligature
|
US7033608B1
(en)
|
1995-05-22 |
2006-04-25 |
The United States Of America As Represented By The Secretary Of The Army |
“Burst-free” sustained release poly-(lactide/glycolide) microspheres
|
US6902743B1
(en)
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
US5747058A
(en)
*
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
BRPI9609033B8
(pt)
*
|
1995-06-07 |
2017-04-04 |
Durect Corp |
composição e emulsão para a liberação controlada de uma substância.
|
US5722950A
(en)
*
|
1995-06-07 |
1998-03-03 |
Atrix Laboratories, Inc. |
Method for remote delivery of an aerosolized liquid
|
US6413536B1
(en)
|
1995-06-07 |
2002-07-02 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system and medical or surgical device
|
US5968542A
(en)
*
|
1995-06-07 |
1999-10-19 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system as a device
|
US7833543B2
(en)
*
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
US5779673A
(en)
*
|
1995-06-26 |
1998-07-14 |
Focal, Inc. |
Devices and methods for application of intraluminal photopolymerized gels
|
US5580568A
(en)
*
|
1995-07-27 |
1996-12-03 |
Micro Therapeutics, Inc. |
Cellulose diacetate compositions for use in embolizing blood vessels
|
US5667767A
(en)
*
|
1995-07-27 |
1997-09-16 |
Micro Therapeutics, Inc. |
Compositions for use in embolizing blood vessels
|
JPH11510837A
(ja)
|
1995-07-28 |
1999-09-21 |
フォーカル,インコーポレイテッド |
薬物送達のための制御された放出薬剤および組織処置薬剤としての使用のためのマルチブロック生分解性ヒドロゲル
|
US5665428A
(en)
*
|
1995-10-25 |
1997-09-09 |
Macromed, Inc. |
Preparation of peptide containing biodegradable microspheres by melt process
|
US5702717A
(en)
*
|
1995-10-25 |
1997-12-30 |
Macromed, Inc. |
Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
|
US5736152A
(en)
*
|
1995-10-27 |
1998-04-07 |
Atrix Laboratories, Inc. |
Non-polymeric sustained release delivery system
|
FR2741628B1
(fr)
*
|
1995-11-29 |
1998-02-06 |
Centre Nat Rech Scient |
Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
US5980945A
(en)
*
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
EP0786259B1
(de)
*
|
1996-01-19 |
2004-03-31 |
United States Surgical Corporation |
Absorbierbare polymer Mischungen und chirurgische Gegenstände daraus
|
US5985312A
(en)
*
|
1996-01-26 |
1999-11-16 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US6368586B1
(en)
|
1996-01-26 |
2002-04-09 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US5702361A
(en)
*
|
1996-01-31 |
1997-12-30 |
Micro Therapeutics, Inc. |
Method for embolizing blood vessels
|
CA2246615C
(en)
*
|
1996-02-20 |
2006-05-09 |
Massachusetts Institute Of Technology |
Biodegradable polymer networks for use in orthopedic and dental applications
|
US5747060A
(en)
*
|
1996-03-26 |
1998-05-05 |
Euro-Celtique, S.A. |
Prolonged local anesthesia with colchicine
|
US7022105B1
(en)
*
|
1996-05-06 |
2006-04-04 |
Novasys Medical Inc. |
Treatment of tissue in sphincters, sinuses and orifices
|
US5921954A
(en)
*
|
1996-07-10 |
1999-07-13 |
Mohr, Jr.; Lawrence G. |
Treating aneurysms by applying hardening/softening agents to hardenable/softenable substances
|
IL118235A0
(en)
*
|
1996-05-13 |
1996-09-12 |
Univ Ben Gurion |
Composition and method for forming biodegradable implants in situ and uses of these implants
|
EP1616563A3
(de)
*
|
1996-05-24 |
2006-01-25 |
Angiotech Pharmaceuticals, Inc. |
Perivaskuläre Verabreichung anti-angiogener Faktoren zur Behandlung oder Prävention von Gefässerkrankungen
|
US6103254A
(en)
*
|
1996-05-31 |
2000-08-15 |
Micro Therapeutics, Inc. |
Methods for sterilizing male mammals
|
AU2745497A
(en)
*
|
1996-05-31 |
1998-01-05 |
Micro Therapeutics, Inc. |
Compositions for use in embolizing blood vessels
|
US20030077317A1
(en)
*
|
1996-06-25 |
2003-04-24 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
|
US5955096A
(en)
*
|
1996-06-25 |
1999-09-21 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
|
US6368356B1
(en)
|
1996-07-11 |
2002-04-09 |
Scimed Life Systems, Inc. |
Medical devices comprising hydrogel polymers having improved mechanical properties
|
US6060534A
(en)
|
1996-07-11 |
2000-05-09 |
Scimed Life Systems, Inc. |
Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
|
US8353908B2
(en)
|
1996-09-20 |
2013-01-15 |
Novasys Medical, Inc. |
Treatment of tissue in sphincters, sinuses, and orifices
|
US6566406B1
(en)
|
1998-12-04 |
2003-05-20 |
Incept, Llc |
Biocompatible crosslinked polymers
|
US8003705B2
(en)
*
|
1996-09-23 |
2011-08-23 |
Incept Llc |
Biocompatible hydrogels made with small molecule precursors
|
ZA978537B
(en)
|
1996-09-23 |
1998-05-12 |
Focal Inc |
Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
|
US20090324721A1
(en)
*
|
1996-09-23 |
2009-12-31 |
Jack Kennedy |
Hydrogels Suitable For Use In Polyp Removal
|
AU4648697A
(en)
*
|
1996-09-23 |
1998-04-14 |
Chandrashekar Pathak |
Methods and devices for preparing protein concentrates
|
US5800412A
(en)
*
|
1996-10-10 |
1998-09-01 |
Sts Biopolymers, Inc. |
Hydrophilic coatings with hydrating agents
|
US7229413B2
(en)
|
1996-11-06 |
2007-06-12 |
Angiotech Biocoatings Corp. |
Echogenic coatings with overcoat
|
US6106473A
(en)
*
|
1996-11-06 |
2000-08-22 |
Sts Biopolymers, Inc. |
Echogenic coatings
|
EP1230902A1
(de)
*
|
1996-11-15 |
2002-08-14 |
Advanced Bio Surfaces, Inc. |
Biomateralsystem für in-situ Gewebewiederherstellung
|
ES2158611T3
(es)
*
|
1996-12-20 |
2001-09-01 |
Alza Corp |
Composicion en gel inyectable con efecto retard y procedimiento para la preparacion de dicha composicion.
|
WO1998029506A1
(en)
|
1996-12-31 |
1998-07-09 |
Kimberly-Clark Worldwide, Inc. |
Water-responsive polymer compositions and method of making the same
|
DE19701912C1
(de)
|
1997-01-10 |
1998-05-14 |
Jenapharm Gmbh |
Injizierbares Implantat
|
US6338726B1
(en)
|
1997-02-06 |
2002-01-15 |
Vidacare, Inc. |
Treating urinary and other body strictures
|
US6630168B1
(en)
*
|
1997-02-20 |
2003-10-07 |
Biomedicines, Inc. |
Gel delivery vehicles for anticellular proliferative agents
|
WO1998041154A1
(en)
*
|
1997-03-20 |
1998-09-24 |
Focal, Inc. |
Biodegradable tissue retractor
|
ES2388248T3
(es)
|
1997-03-31 |
2012-10-11 |
Boston Scientific Scimed Limited |
Forma de dosificación que comprende taxol en forma cristalina
|
NZ501184A
(en)
|
1997-04-30 |
2002-08-28 |
Guilford Pharm Inc |
Biodegradable poly (phosphodiester) compositions that degrade in vivo into non-toxic residues
|
US20060025328A1
(en)
*
|
1997-05-28 |
2006-02-02 |
Burns Patrick J |
Compositions suitable for controlled release of the hormone GnRH and its analogs
|
DK0996426T3
(da)
|
1997-06-05 |
2007-07-02 |
Bertex Pharma Gmbh |
Multifasesystem
|
DE19724784A1
(de)
*
|
1997-06-05 |
1998-12-10 |
Roland Prof Dr Bodmeier |
Verfahren zur in-situ Herstellung von Partikeln
|
CA2291622C
(en)
|
1997-06-06 |
2007-09-04 |
Anna Gutowska |
Reversible geling co-polymer and method of making
|
US5962006A
(en)
*
|
1997-06-17 |
1999-10-05 |
Atrix Laboratories, Inc. |
Polymer formulation for prevention of surgical adhesions
|
DE19726412A1
(de)
*
|
1997-06-21 |
1998-12-24 |
Merck Patent Gmbh |
Implantatmaterial mit einer Träger-Wirkstoff-Kombination
|
US7923250B2
(en)
|
1997-07-30 |
2011-04-12 |
Warsaw Orthopedic, Inc. |
Methods of expressing LIM mineralization protein in non-osseous cells
|
EP1007673B1
(de)
|
1997-07-30 |
2008-12-17 |
Emory University |
Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme
|
US6552162B1
(en)
|
1997-07-31 |
2003-04-22 |
Kimberly-Clark Worldwide, Inc. |
Water-responsive, biodegradable compositions and films and articles comprising a blend of polylactide and polyvinyl alcohol and methods for making the same
|
US6075118A
(en)
*
|
1997-07-31 |
2000-06-13 |
Kimberly-Clark Worldwide, Inc. |
Water-responsive, biodegradable film compositions comprising polylactide and polyvinyl alcohol, and a method for making the films
|
US5952433A
(en)
*
|
1997-07-31 |
1999-09-14 |
Kimberly-Clark Worldwide, Inc. |
Modified polyactide compositions and a reactive-extrusion process to make the same
|
US5945480A
(en)
*
|
1997-07-31 |
1999-08-31 |
Kimberly-Clark Worldwide, Inc. |
Water-responsive, biodegradable fibers comprising polylactide modified polylactide and polyvinyl alcohol, and method for making the fibers
|
ZA987019B
(en)
*
|
1997-08-06 |
1999-06-04 |
Focal Inc |
Hemostatic tissue sealants
|
US9023031B2
(en)
*
|
1997-08-13 |
2015-05-05 |
Verathon Inc. |
Noninvasive devices, methods, and systems for modifying tissues
|
AUPO907697A0
(en)
|
1997-09-09 |
1997-10-02 |
Day, Robert Edward |
Chemical supplementation of bone
|
US5989463A
(en)
*
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
US6117949A
(en)
*
|
1998-10-01 |
2000-09-12 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6004573A
(en)
*
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6201072B1
(en)
|
1997-10-03 |
2001-03-13 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6569417B2
(en)
*
|
1997-10-10 |
2003-05-27 |
Micro Therapeutics, Inc. |
Methods for treating urinary incontinence in mammals
|
US8668737B2
(en)
|
1997-10-10 |
2014-03-11 |
Senorx, Inc. |
Tissue marking implant
|
US7637948B2
(en)
*
|
1997-10-10 |
2009-12-29 |
Senorx, Inc. |
Tissue marking implant
|
US6417247B1
(en)
*
|
1997-10-14 |
2002-07-09 |
Beth L. Armstrong |
Polymer/ceramic composites
|
AU743819B2
(en)
*
|
1997-10-27 |
2002-02-07 |
California Institute Of Technology |
Methods and pharmaceutical compositions for the closure of retinal breaks
|
US20020164374A1
(en)
*
|
1997-10-29 |
2002-11-07 |
John Jackson |
Polymeric systems for drug delivery and uses thereof
|
US6193991B1
(en)
|
1997-10-29 |
2001-02-27 |
Atul J. Shukla |
Biodegradable delivery systems of biologically active substances
|
US6015541A
(en)
*
|
1997-11-03 |
2000-01-18 |
Micro Therapeutics, Inc. |
Radioactive embolizing compositions
|
NZ330596A
(en)
|
1998-06-05 |
2001-02-23 |
Dec Res |
Intravaginal devices allowing for increased uptake of active ingredients
|
CA2311311C
(en)
*
|
1997-11-21 |
2008-05-06 |
Interag |
Biodegradable intra vaginal devices
|
ES2217738T3
(es)
*
|
1998-01-29 |
2004-11-01 |
Poly-Med Inc. |
Microparticulas absorbibles.
|
JP2002501907A
(ja)
|
1998-01-29 |
2002-01-22 |
キナートン・リミテッド |
吸収可能なマイクロ粒子の製造法
|
US20100114087A1
(en)
*
|
1998-02-19 |
2010-05-06 |
Edwards Stuart D |
Methods and devices for treating urinary incontinence
|
US6733767B2
(en)
*
|
1998-03-19 |
2004-05-11 |
Merck & Co., Inc. |
Liquid polymeric compositions for controlled release of bioactive substances
|
US6161034A
(en)
*
|
1999-02-02 |
2000-12-12 |
Senorx, Inc. |
Methods and chemical preparations for time-limited marking of biopsy sites
|
US7087244B2
(en)
*
|
2000-09-28 |
2006-08-08 |
Battelle Memorial Institute |
Thermogelling oligopeptide polymers
|
US6841617B2
(en)
*
|
2000-09-28 |
2005-01-11 |
Battelle Memorial Institute |
Thermogelling biodegradable aqueous polymer solution
|
US20040228794A1
(en)
*
|
1998-04-10 |
2004-11-18 |
Battelle Memorial Institute |
Therapeutic agent carrier compositions
|
US7128927B1
(en)
|
1998-04-14 |
2006-10-31 |
Qlt Usa, Inc. |
Emulsions for in-situ delivery systems
|
DE69921636T2
(de)
*
|
1998-04-20 |
2005-11-03 |
Genzyme Corp., Cambridge |
Medikamentöse verabreichung von proteinen aus polymergemischen
|
US6177094B1
(en)
|
1998-04-30 |
2001-01-23 |
United States Surgical Corporation |
Bioabsorbable blends and coating composition containing same
|
US6350518B1
(en)
|
1998-06-01 |
2002-02-26 |
Kimberly-Clark Worldwide, Inc. |
Methods of making blend compositions of an unmodified poly vinyl alcohol and a thermoplastic elastomer
|
US6933326B1
(en)
|
1998-06-19 |
2005-08-23 |
Lifecell Coporation |
Particulate acellular tissue matrix
|
WO1999066797A1
(en)
|
1998-06-22 |
1999-12-29 |
Worden Charles E |
Enriched platelet wound healant
|
US6245345B1
(en)
|
1998-07-07 |
2001-06-12 |
Atrix Laboratories, Inc. |
Filamentous porous films and methods for producing the same
|
US6261583B1
(en)
|
1998-07-28 |
2001-07-17 |
Atrix Laboratories, Inc. |
Moldable solid delivery system
|
US6605294B2
(en)
*
|
1998-08-14 |
2003-08-12 |
Incept Llc |
Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
|
US6632457B1
(en)
*
|
1998-08-14 |
2003-10-14 |
Incept Llc |
Composite hydrogel drug delivery systems
|
CA2340381C
(en)
*
|
1998-08-14 |
2009-01-13 |
Incept Llc |
Methods and apparatus for in situ formation of hydrogels
|
US6818018B1
(en)
*
|
1998-08-14 |
2004-11-16 |
Incept Llc |
In situ polymerizable hydrogels
|
US6703047B2
(en)
|
2001-02-02 |
2004-03-09 |
Incept Llc |
Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
|
US6179862B1
(en)
|
1998-08-14 |
2001-01-30 |
Incept Llc |
Methods and apparatus for in situ formation of hydrogels
|
US6152943A
(en)
*
|
1998-08-14 |
2000-11-28 |
Incept Llc |
Methods and apparatus for intraluminal deposition of hydrogels
|
AU6240099A
(en)
*
|
1998-08-24 |
2000-03-14 |
Susan E Draheim |
Methods and compositions for treating periodontal disease with an inhibitor of secretory phospholipase A2
|
US6153212A
(en)
|
1998-10-02 |
2000-11-28 |
Guilford Pharmaceuticals Inc. |
Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same
|
US6419709B1
(en)
*
|
1998-10-02 |
2002-07-16 |
Guilford Pharmaceuticals, Inc. |
Biodegradable terephthalate polyester-poly(Phosphite) compositions, articles, and methods of using the same
|
US6143314A
(en)
|
1998-10-28 |
2000-11-07 |
Atrix Laboratories, Inc. |
Controlled release liquid delivery compositions with low initial drug burst
|
US6565874B1
(en)
*
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
US7767708B2
(en)
*
|
1998-11-04 |
2010-08-03 |
Schering-Plough Animal Health Corp. |
Growth stimulant compositions
|
US6110484A
(en)
|
1998-11-24 |
2000-08-29 |
Cohesion Technologies, Inc. |
Collagen-polymer matrices with differential biodegradability
|
US20080114092A1
(en)
*
|
1998-12-04 |
2008-05-15 |
Incept Llc |
Adhesion barriers applicable by minimally invasive surgery and methods of use thereof
|
US6200550B1
(en)
|
1998-12-11 |
2001-03-13 |
Q-Pharma, Inc. |
Oral care compositions comprising coenzyme Q10
|
US6231613B1
(en)
|
1998-12-15 |
2001-05-15 |
Enteric Medical Technologies, Inc. |
Methods for soft tissue augmentation in mammals
|
US6862470B2
(en)
|
1999-02-02 |
2005-03-01 |
Senorx, Inc. |
Cavity-filling biopsy site markers
|
US7651505B2
(en)
|
2002-06-17 |
2010-01-26 |
Senorx, Inc. |
Plugged tip delivery for marker placement
|
US6725083B1
(en)
|
1999-02-02 |
2004-04-20 |
Senorx, Inc. |
Tissue site markers for in VIVO imaging
|
US20090030309A1
(en)
*
|
2007-07-26 |
2009-01-29 |
Senorx, Inc. |
Deployment of polysaccharide markers
|
US8361082B2
(en)
|
1999-02-02 |
2013-01-29 |
Senorx, Inc. |
Marker delivery device with releasable plug
|
US8498693B2
(en)
*
|
1999-02-02 |
2013-07-30 |
Senorx, Inc. |
Intracorporeal marker and marker delivery device
|
US9820824B2
(en)
|
1999-02-02 |
2017-11-21 |
Senorx, Inc. |
Deployment of polysaccharide markers for treating a site within a patent
|
US7983734B2
(en)
|
2003-05-23 |
2011-07-19 |
Senorx, Inc. |
Fibrous marker and intracorporeal delivery thereof
|
DE19908753C2
(de)
|
1999-02-20 |
2003-10-02 |
Jenapharm Gmbh |
Bioabbaubare, injizierbare Oligomer-Polymer-Zusammensetzung
|
US6203779B1
(en)
|
1999-03-19 |
2001-03-20 |
Charlie Ricci |
Methods for treating endoleaks during endovascular repair of abdominal aortic aneurysms
|
US6303100B1
(en)
|
1999-03-19 |
2001-10-16 |
Micro Therapeutics, Inc. |
Methods for inhibiting the formation of potential endoleaks associated with endovascular repair of abdominal aortic aneurysms
|
EP2305324B1
(de)
|
1999-03-25 |
2014-09-17 |
Metabolix, Inc. |
Medizinische Geräte und Anwendungen aus Polyhydroxyalkanoat-Polymeren
|
US7341602B2
(en)
*
|
1999-05-10 |
2008-03-11 |
Fell Barry M |
Proportioned surgically implantable knee prosthesis
|
US6206927B1
(en)
|
1999-04-02 |
2001-03-27 |
Barry M. Fell |
Surgically implantable knee prothesis
|
DE19916131A1
(de)
*
|
1999-04-09 |
2000-10-26 |
S & C Polymer Silicon & Compos |
Adhesivsystem für Silicone
|
DE60038010T2
(de)
*
|
1999-04-12 |
2009-03-05 |
Cornell Research Foundation, Inc. |
Hydrogel-formendes system mit hydrophoben und hydrophilen komponenten
|
US6716445B2
(en)
*
|
1999-04-12 |
2004-04-06 |
Cornell Research Foundation, Inc. |
Hydrogel entrapping therapeutic agent and stent with coating comprising this
|
WO2000064977A1
(en)
*
|
1999-04-26 |
2000-11-02 |
California Institute Of Technology |
In situ forming hydrogels
|
US6858229B1
(en)
|
1999-04-26 |
2005-02-22 |
California Institute Of Technology |
In situ forming hydrogels
|
US6554851B1
(en)
|
1999-05-07 |
2003-04-29 |
Scimed Life Systems, Inc. |
Methods of sealing an injection site
|
US6893463B2
(en)
*
|
1999-05-10 |
2005-05-17 |
Barry M. Fell |
Surgically implantable knee prosthesis having two-piece keyed components
|
US6911044B2
(en)
*
|
1999-05-10 |
2005-06-28 |
Barry M. Fell |
Surgically implantable knee prosthesis having medially shifted tibial surface
|
US6923831B2
(en)
*
|
1999-05-10 |
2005-08-02 |
Barry M. Fell |
Surgically implantable knee prosthesis having attachment apertures
|
US6966928B2
(en)
|
1999-05-10 |
2005-11-22 |
Fell Barry M |
Surgically implantable knee prosthesis having keels
|
US6855165B2
(en)
*
|
1999-05-10 |
2005-02-15 |
Barry M. Fell |
Surgically implantable knee prosthesis having enlarged femoral surface
|
US6866684B2
(en)
|
1999-05-10 |
2005-03-15 |
Barry M. Fell |
Surgically implantable knee prosthesis having different tibial and femoral surface profiles
|
US6333020B1
(en)
|
1999-05-13 |
2001-12-25 |
Micro Therapeutics, Inc. |
Methods for treating AVM's using radio active compositions
|
US6241719B1
(en)
|
1999-05-13 |
2001-06-05 |
Micro Therapeutics, Inc. |
Method for forming a radioactive stent
|
US7018365B2
(en)
|
1999-05-21 |
2006-03-28 |
Micro Therapeutics, Inc. |
Threaded syringe with quick stop
|
ES2319725T3
(es)
|
1999-05-21 |
2009-05-12 |
Micro Therapeutics, Inc. |
Composiciones embolizantes de alta viscosidad.
|
US6645167B1
(en)
*
|
1999-05-21 |
2003-11-11 |
Micro Therapeutics, Inc. |
Methods for embolizing vascular sites with an embolizing composition
|
JP2003500106A
(ja)
|
1999-05-21 |
2003-01-07 |
マイクロ・セラピューティクス・インコーポレーテッド |
一様分散させた高粘度塞栓性組成物を生体内で搬送するための方法
|
JP2003501375A
(ja)
*
|
1999-06-04 |
2003-01-14 |
アルザ・コーポレーション |
移植可能なゲル組成物および製造方法
|
EP1949890A3
(de)
|
1999-06-04 |
2011-05-18 |
ALZA Corporation |
Implantierbare Gelzusammensetzungen und Herstellungsverfahren dafür
|
WO2000076555A1
(en)
*
|
1999-06-11 |
2000-12-21 |
Pro Duct Health, Inc. |
Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue
|
US6575991B1
(en)
|
1999-06-17 |
2003-06-10 |
Inrad, Inc. |
Apparatus for the percutaneous marking of a lesion
|
US6521431B1
(en)
*
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
US6541020B1
(en)
|
1999-07-09 |
2003-04-01 |
Trimeris, Inc. |
Methods and compositions for administration of therapeutic reagents
|
US6179840B1
(en)
|
1999-07-23 |
2001-01-30 |
Ethicon, Inc. |
Graft fixation device and method
|
US20020095157A1
(en)
|
1999-07-23 |
2002-07-18 |
Bowman Steven M. |
Graft fixation device combination
|
US7008635B1
(en)
*
|
1999-09-10 |
2006-03-07 |
Genzyme Corporation |
Hydrogels for orthopedic repair
|
US7025980B1
(en)
|
1999-09-14 |
2006-04-11 |
Tepha, Inc. |
Polyhydroxyalkanoate compositions for soft tissue repair, augmentation, and viscosupplementation
|
US20020055708A1
(en)
*
|
1999-09-24 |
2002-05-09 |
Peterson Kenneth R. |
Coupling syringe system and methods for obtaining a mixed composition
|
US8226598B2
(en)
*
|
1999-09-24 |
2012-07-24 |
Tolmar Therapeutics, Inc. |
Coupling syringe system and methods for obtaining a mixed composition
|
US6420378B1
(en)
|
1999-10-15 |
2002-07-16 |
Supergen, Inc. |
Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
|
ES2491866T3
(es)
*
|
1999-11-15 |
2014-09-08 |
Piramal Healthcare (Canada) Limited |
Disolución biopolimérica acuosa autogelificante controlada por la temperatura y dependiente del pH
|
US6461631B1
(en)
|
1999-11-16 |
2002-10-08 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
US6682754B2
(en)
*
|
1999-11-24 |
2004-01-27 |
Willmar Poultry Company, Inc. |
Ovo delivery of an immunogen containing implant
|
US20030158302A1
(en)
*
|
1999-12-09 |
2003-08-21 |
Cyric Chaput |
Mineral-polymer hybrid composition
|
DE60003459T2
(de)
*
|
1999-12-09 |
2004-05-06 |
Biosyntech Canada Inc., Laval |
Mineral-polymer hybrid-zusammensetzung
|
US20010037091A1
(en)
*
|
1999-12-29 |
2001-11-01 |
Wironen John F. |
System for reconstituting pastes and methods of using same
|
DK1248596T3
(da)
*
|
2000-01-11 |
2007-07-02 |
Bertex Pharma Gmbh |
Implantater, partikler
|
US7097855B1
(en)
|
2000-01-31 |
2006-08-29 |
Massachusetts Institute Of Technology |
Transdermal thermal polymerization
|
US6491672B2
(en)
|
2000-02-10 |
2002-12-10 |
Harmonia Medical Technologies, Inc. |
Transurethral volume reduction of the prostate (TUVOR)
|
FI20000317A
(fi)
*
|
2000-02-15 |
2001-08-16 |
Jvs Polymers Oy |
Biologisesti hajoava materiaali
|
DE60130544T2
(de)
|
2000-03-13 |
2008-06-26 |
Biocure, Inc. |
Embolische zusammensetzungen
|
US6652883B2
(en)
|
2000-03-13 |
2003-11-25 |
Biocure, Inc. |
Tissue bulking and coating compositions
|
US6632246B1
(en)
|
2000-03-14 |
2003-10-14 |
Chondrosite, Llc |
Cartilage repair plug
|
US6626945B2
(en)
|
2000-03-14 |
2003-09-30 |
Chondrosite, Llc |
Cartilage repair plug
|
CA2427543A1
(en)
*
|
2000-03-15 |
2004-11-02 |
Yu-Ling Cheng |
Thermally reversible implant and filler
|
US7193007B2
(en)
*
|
2000-03-15 |
2007-03-20 |
Yu-Ling Cheng |
Environment responsive gelling copolymer
|
US20030211974A1
(en)
*
|
2000-03-21 |
2003-11-13 |
Brodbeck Kevin J. |
Gel composition and methods
|
US6626870B1
(en)
|
2000-03-27 |
2003-09-30 |
Artix Laboratories, Inc. |
Stoppering method to maintain sterility
|
US6566144B1
(en)
|
2000-03-27 |
2003-05-20 |
Atrix Laboratories |
Cover plate for use in lyophilization
|
EP1142596A1
(de)
*
|
2000-04-03 |
2001-10-10 |
Universiteit Gent |
Zusammensetzung von vernetzbaren Prepolymeren zum Gebrauch in therapeutisch aktiven, bioabbaubaren Implantaten
|
EP1274459B1
(de)
|
2000-04-19 |
2005-11-16 |
Genentech, Inc. |
Formulierungen mit verzögerter freisetzung enthaltend wachstumshormon
|
US6800671B1
(en)
*
|
2000-04-21 |
2004-10-05 |
Britesmile, Inc. |
Low peak exotherm curable compositions
|
US6550482B1
(en)
*
|
2000-04-21 |
2003-04-22 |
Vascular Control Systems, Inc. |
Methods for non-permanent occlusion of a uterine artery
|
US7018645B1
(en)
*
|
2000-04-27 |
2006-03-28 |
Macromed, Inc. |
Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
|
JP2004511431A
(ja)
*
|
2000-06-28 |
2004-04-15 |
アトゥル・ジェイ・シュクラ |
生物活性物質を含む生分解性ビヒクルおよび送達システム
|
BR0112109A
(pt)
*
|
2000-06-29 |
2007-05-29 |
Biosyntech Canada Inc |
composição e método para a correção e regeneração de cartilagem e outros tecidos
|
GB0017999D0
(en)
*
|
2000-07-21 |
2000-09-13 |
Smithkline Beecham Biolog |
Novel device
|
DE10037983B4
(de)
*
|
2000-08-03 |
2006-04-13 |
Stefan Zikeli |
Polymerzusammensetzung und daraus hergestellter Formkörper mit einem Gehalt an Alkaloid
|
EP1315470B1
(de)
|
2000-08-28 |
2009-07-15 |
Disc Dynamics, Inc. |
System zur wiederherstellung von gelenkoberflächen von säugetieren
|
US6620196B1
(en)
*
|
2000-08-30 |
2003-09-16 |
Sdgi Holdings, Inc. |
Intervertebral disc nucleus implants and methods
|
DE10044545A1
(de)
*
|
2000-09-05 |
2002-04-04 |
Roland Bodmeier |
Retardpartikeldispersion
|
AU2001288829A1
(en)
*
|
2000-09-06 |
2002-03-22 |
Ap Pharma, Inc. |
Degradable polyacetal polymers
|
US7306591B2
(en)
|
2000-10-02 |
2007-12-11 |
Novasys Medical, Inc. |
Apparatus and methods for treating female urinary incontinence
|
AU2001296770A1
(en)
*
|
2000-10-06 |
2002-04-15 |
Durect Corporation |
Devices and methods for management of inflammation
|
CA2409104A1
(en)
|
2000-10-11 |
2002-04-18 |
Micro Therapeutics, Inc. |
Methods for treating aneurysms
|
US8470359B2
(en)
|
2000-11-13 |
2013-06-25 |
Qlt Usa, Inc. |
Sustained release polymer
|
CA2429168C
(en)
*
|
2000-11-15 |
2010-06-08 |
Bio Syntech Canada Inc. |
Method for restoring a damaged or degenerated intervertebral disc
|
US6565601B2
(en)
*
|
2000-11-15 |
2003-05-20 |
Micro Therapeutics, Inc. |
Methods for vascular reconstruction of diseased arteries
|
US6726898B2
(en)
|
2000-11-17 |
2004-04-27 |
Gary R. Jernberg |
Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
|
US6576226B1
(en)
|
2000-11-17 |
2003-06-10 |
Gary R. Jernberg |
Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
|
US6648911B1
(en)
|
2000-11-20 |
2003-11-18 |
Avantec Vascular Corporation |
Method and device for the treatment of vulnerable tissue site
|
CA2659518A1
(en)
*
|
2000-11-20 |
2002-05-30 |
Senorx, Inc. |
Tissue site markers for in vivo imaging
|
US20020106406A1
(en)
*
|
2000-12-08 |
2002-08-08 |
Mchugh Anthony J. |
Crystallizable/non-crystallizable polymer composites
|
US6852330B2
(en)
*
|
2000-12-21 |
2005-02-08 |
Depuy Mitek, Inc. |
Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
|
CA2365376C
(en)
|
2000-12-21 |
2006-03-28 |
Ethicon, Inc. |
Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
|
US6599323B2
(en)
*
|
2000-12-21 |
2003-07-29 |
Ethicon, Inc. |
Reinforced tissue implants and methods of manufacture and use
|
US9080146B2
(en)
*
|
2001-01-11 |
2015-07-14 |
Celonova Biosciences, Inc. |
Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
|
ATE359094T1
(de)
*
|
2001-02-14 |
2007-05-15 |
Genzyme Corp |
Biokompatibles vlies für hämostase und gewebeaufbau
|
CA2439120C
(en)
*
|
2001-02-23 |
2011-07-05 |
Genentech, Inc. |
Erodible polymers for injection
|
US6913765B2
(en)
*
|
2001-03-21 |
2005-07-05 |
Scimed Life Systems, Inc. |
Controlling resorption of bioresorbable medical implant material
|
WO2002082973A2
(en)
*
|
2001-04-16 |
2002-10-24 |
Board Of Regents, The University Of Texas System |
Osteotropic biomaterials, methods of use thereof and implant systems incorporating the same
|
AU2002308522A1
(en)
|
2001-05-01 |
2002-11-11 |
University Of Southern California |
Methods for inhibiting tumor cell proliferation
|
US6590059B2
(en)
*
|
2001-05-11 |
2003-07-08 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters from dioxolane-based diketene acetals
|
US20030152630A1
(en)
*
|
2001-05-11 |
2003-08-14 |
Ng Steven Y. |
PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
|
US7455657B2
(en)
*
|
2001-06-19 |
2008-11-25 |
Boston Scientific Scimed, Inc |
Method and apparatus to modify a fluid using a selectively permeable membrane
|
US7318931B2
(en)
*
|
2001-06-21 |
2008-01-15 |
Genentech, Inc. |
Sustained release formulation
|
US6730772B2
(en)
|
2001-06-22 |
2004-05-04 |
Venkatram P. Shastri |
Degradable polymers from derivatized ring-opened epoxides
|
GB0116341D0
(en)
*
|
2001-07-04 |
2001-08-29 |
Smith & Nephew |
Biodegradable polymer systems
|
US7345144B2
(en)
*
|
2001-07-11 |
2008-03-18 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment of cachexia
|
US7342089B2
(en)
*
|
2001-07-11 |
2008-03-11 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment for cachexia
|
US20030026770A1
(en)
*
|
2001-07-25 |
2003-02-06 |
Szymaitis Dennis W. |
Periodontal regeneration composition and method of using same
|
US7105182B2
(en)
*
|
2001-07-25 |
2006-09-12 |
Szymaitis Dennis W |
Periodontal regeneration composition and method of using same
|
WO2003013571A1
(en)
*
|
2001-08-10 |
2003-02-20 |
Palatin Technologies, Inc. |
Peptidomimetics of biologically active metallopeptides
|
US7732451B2
(en)
*
|
2001-08-10 |
2010-06-08 |
Palatin Technologies, Inc. |
Naphthalene-containing melanocortin receptor-specific small molecule
|
US7655658B2
(en)
*
|
2001-08-10 |
2010-02-02 |
Palatin Technologies, Inc. |
Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
|
US7456184B2
(en)
*
|
2003-05-01 |
2008-11-25 |
Palatin Technologies Inc. |
Melanocortin receptor-specific compounds
|
US7718802B2
(en)
|
2001-08-10 |
2010-05-18 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
US20030082235A1
(en)
*
|
2001-08-13 |
2003-05-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Novel reverse thermo-sensitive block copolymers
|
US20080063620A1
(en)
*
|
2001-08-13 |
2008-03-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Novel reverse thermo-sensitive block copolymers
|
US20030060422A1
(en)
|
2001-08-31 |
2003-03-27 |
Balaji Venkataraman |
Tannate compositions and methods of treatment
|
US7081475B2
(en)
|
2001-09-14 |
2006-07-25 |
Prolx Pharmaceuticals Corp. |
Wortmannin analogs and methods of using same
|
US7309498B2
(en)
*
|
2001-10-10 |
2007-12-18 |
Belenkaya Bronislava G |
Biodegradable absorbents and methods of preparation
|
JP4125234B2
(ja)
|
2001-11-01 |
2008-07-30 |
スパイン・ウェイブ・インコーポレーテッド |
椎間板間の終板の前処理のための装置及び方法
|
AU2002336694A1
(en)
*
|
2001-11-01 |
2003-05-12 |
Lawrence M. Boyd |
Devices and methods for the restoration of a spinal disc
|
US7488320B2
(en)
*
|
2001-11-01 |
2009-02-10 |
Renova Orthopedics, Llc |
Orthopaedic implant fixation using an in-situ formed anchor
|
NZ533435A
(en)
*
|
2001-11-14 |
2007-10-26 |
Alza Corp |
Injectable depot compositions and uses thereof
|
US20070196415A1
(en)
*
|
2002-11-14 |
2007-08-23 |
Guohua Chen |
Depot compositions with multiple drug release rate controls and uses thereof
|
CA2467239A1
(en)
*
|
2001-11-14 |
2003-05-22 |
Alza Corporation |
Catheter injectable depot compositions and uses thereof
|
MXPA04004664A
(es)
*
|
2001-11-14 |
2004-09-10 |
Alza Corp |
Composiciones de deposito inyectables.
|
US6524606B1
(en)
*
|
2001-11-16 |
2003-02-25 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters containing amine groups
|
GB2399309A
(en)
*
|
2001-12-19 |
2004-09-15 |
Advanced Bio Surfaces Inc |
Bone smoothing method and system
|
JP2005514985A
(ja)
*
|
2002-01-14 |
2005-05-26 |
マイクロ セラピューティクス, インコーポレイテッド |
高粘度塞栓組成物を用いて動脈瘤部位を塞栓するための方法
|
US20050058698A1
(en)
*
|
2002-01-21 |
2005-03-17 |
Nolan Yvonne Mairead |
Pharmaceutically acceptable phosphate-glycerol carrying bodies and uses relating to Parkinson's Disease
|
JP4324478B2
(ja)
*
|
2002-01-22 |
2009-09-02 |
アドバンスト バイオ サーフェイシズ,インコーポレイティド |
間置関節形成システム
|
GB0202233D0
(en)
*
|
2002-01-31 |
2002-03-20 |
Smith & Nephew |
Bioresorbable polymers
|
US8088388B2
(en)
*
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
WO2003071986A2
(en)
*
|
2002-02-22 |
2003-09-04 |
Control Delivery Systems, Inc. |
Method for treating otic disorders
|
AU2003216424A1
(en)
*
|
2002-02-25 |
2003-10-08 |
Guilford Pharmaceuticals, Inc. |
Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
|
US7361369B2
(en)
*
|
2002-02-28 |
2008-04-22 |
William Marsh Rice University |
Implant with structure allowing injection of polymer for attaching implant to tissue
|
EP1344538A1
(de)
*
|
2002-03-14 |
2003-09-17 |
Degradable Solutions AG |
Poröses und bioabbaubares Implantatmaterial und Verfahren zu seiner Herstellung
|
JP2005526079A
(ja)
*
|
2002-03-15 |
2005-09-02 |
サイプレス バイオサイエンス, インコーポレイテッド |
内蔵痛症候群を処置するためのneおよび5−ht再取り込み阻害剤
|
AU2003225516A1
(en)
*
|
2002-03-26 |
2003-10-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Responsive biomedical composites
|
US20030203000A1
(en)
*
|
2002-04-24 |
2003-10-30 |
Schwarz Marlene C. |
Modulation of therapeutic agent release from a polymeric carrier using solvent-based techniques
|
US7432245B2
(en)
*
|
2002-06-07 |
2008-10-07 |
Abbott Laboratories Inc. |
Pharmaceutical formulation comprising a peptide angiogenesis inhibitor
|
US20030228365A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Fortuna Haviv |
Pharmaceutical formulation
|
US20030228366A1
(en)
*
|
2002-06-11 |
2003-12-11 |
Chung Shih |
Reconstitutable compositions of biodegradable block copolymers
|
US7649023B2
(en)
*
|
2002-06-11 |
2010-01-19 |
Novartis Ag |
Biodegradable block copolymeric compositions for drug delivery
|
US7037983B2
(en)
*
|
2002-06-14 |
2006-05-02 |
Kimberly-Clark Worldwide, Inc. |
Methods of making functional biodegradable polymers
|
US20030232088A1
(en)
*
|
2002-06-14 |
2003-12-18 |
Kimberly-Clark Worldwide, Inc. |
Materials with both bioadhesive and biodegradable components
|
US20040001889A1
(en)
*
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
AR039729A1
(es)
|
2002-06-25 |
2005-03-09 |
Alza Corp |
Formulaciones de deposito de corta duracion
|
US20080226723A1
(en)
*
|
2002-07-05 |
2008-09-18 |
Celonova Biosciences, Inc. |
Loadable Polymeric Particles for Therapeutic Use in Erectile Dysfunction and Methods of Preparing and Using the Same
|
US7160551B2
(en)
*
|
2002-07-09 |
2007-01-09 |
The Board Of Trustees Of The University Of Illinois |
Injectable system for controlled drug delivery
|
ES2309350T3
(es)
*
|
2002-07-11 |
2008-12-16 |
Advanced Bio Surfaces, Inc. |
Metodo y equipo para artroplastia interposicional.
|
DE10331419A1
(de)
*
|
2002-07-12 |
2004-01-22 |
Mycrona Gesellschaft für innovative Messtechnik mbH |
Verfahren und Vorrichtung zur Bestimmung der Ist-Position einer Struktur eines Untersuchungsobjektes
|
IL166418A0
(en)
*
|
2002-07-31 |
2006-01-15 |
Alza Corp |
Injectable depot compositions and uses thereof
|
CA2494400A1
(en)
*
|
2002-07-31 |
2004-02-05 |
Alza Corporation |
Injectable multimodal polymer depot compositions and uses thereof
|
US7041111B2
(en)
|
2002-08-02 |
2006-05-09 |
Boston Scientific Scimed, Inc. |
Placing sutures
|
US8062573B2
(en)
*
|
2002-09-16 |
2011-11-22 |
Theraject, Inc. |
Solid micro-perforators and methods of use
|
US20040078090A1
(en)
|
2002-10-18 |
2004-04-22 |
Francois Binette |
Biocompatible scaffolds with tissue fragments
|
US6800663B2
(en)
*
|
2002-10-18 |
2004-10-05 |
Alkermes Controlled Therapeutics Inc. Ii, |
Crosslinked hydrogel copolymers
|
US7824701B2
(en)
|
2002-10-18 |
2010-11-02 |
Ethicon, Inc. |
Biocompatible scaffold for ligament or tendon repair
|
US20060003004A1
(en)
*
|
2002-10-25 |
2006-01-05 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
US20040121010A1
(en)
*
|
2002-10-25 |
2004-06-24 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
MXPA05004927A
(es)
*
|
2002-11-06 |
2005-09-08 |
Alza Corp |
Formulaciones de deposito de liberacion controlada.
|
HUE033832T2
(en)
|
2002-11-15 |
2018-01-29 |
Idenix Pharmaceuticals Llc |
2'-methyl nucleosides in combination with interferon and Flaviviridae mutation
|
US20060036158A1
(en)
|
2003-11-17 |
2006-02-16 |
Inrad, Inc. |
Self-contained, self-piercing, side-expelling marking apparatus
|
CA2507522C
(en)
*
|
2002-12-13 |
2015-02-24 |
Durect Corporation |
Oral drug delivery system
|
EP1592453A1
(de)
*
|
2003-01-28 |
2005-11-09 |
Collegium Pharmaceutical, Inc. |
Multiparticulate aufbau von milnacipran für orale einnahme
|
WO2004071356A2
(en)
*
|
2003-02-10 |
2004-08-26 |
Smith & Nephew, Inc. |
Resorbable devices
|
US20040197301A1
(en)
*
|
2003-02-18 |
2004-10-07 |
Zhong Zhao |
Hybrid polymers and methods of making the same
|
US20050025707A1
(en)
*
|
2003-02-27 |
2005-02-03 |
Patterson William R. |
Fumed silica embolic compositions
|
US8197837B2
(en)
|
2003-03-07 |
2012-06-12 |
Depuy Mitek, Inc. |
Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
|
EP1622540A4
(de)
*
|
2003-03-11 |
2009-12-30 |
Qlt Usa Inc |
Formulierungen für zellen-plan-abhängige krebsmittel
|
US9445901B2
(en)
*
|
2003-03-12 |
2016-09-20 |
Deger C. Tunc |
Prosthesis with sustained release analgesic
|
US20060076295A1
(en)
*
|
2004-03-15 |
2006-04-13 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods of blood-based therapies having a microfluidic membraneless exchange device
|
ATE510605T1
(de)
|
2003-03-14 |
2011-06-15 |
Univ Columbia |
Systeme und verfahren für auf blut basierende therapien mit einer membranlosen mikrofluid- austauschvorrichtung
|
GB0307011D0
(en)
*
|
2003-03-27 |
2003-04-30 |
Regentec Ltd |
Porous matrix
|
DE10314082A1
(de)
*
|
2003-03-28 |
2004-10-21 |
Mcs Micro Carrier Systems Gmbh |
Biodegradierbares injizierbares Implantat
|
US20040202694A1
(en)
*
|
2003-04-11 |
2004-10-14 |
Vascular Control Systems, Inc. |
Embolic occlusion of uterine arteries
|
US8404269B2
(en)
*
|
2003-04-11 |
2013-03-26 |
Michael Snyder |
Sustained release implantable eye device
|
US7968548B2
(en)
|
2003-05-01 |
2011-06-28 |
Palatin Technologies, Inc. |
Melanocortin receptor-specific piperazine compounds with diamine groups
|
US7727990B2
(en)
|
2003-05-01 |
2010-06-01 |
Palatin Technologies, Inc. |
Melanocortin receptor-specific piperazine and keto-piperazine compounds
|
US7727991B2
(en)
|
2003-05-01 |
2010-06-01 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific single acyl piperazine compounds
|
DK1638615T3
(en)
|
2003-05-08 |
2015-01-12 |
Tepha Inc |
MEDICAL POLYHYDROXYALKANOATE TEXTILES AND FIBERS
|
IL155866A0
(en)
*
|
2003-05-12 |
2003-12-23 |
Yissum Res Dev Co |
Responsive polymeric system
|
US20040247672A1
(en)
*
|
2003-05-16 |
2004-12-09 |
Alkermes Controlled Therapeutics, Inc. |
Injectable sustained release compositions
|
US7877133B2
(en)
*
|
2003-05-23 |
2011-01-25 |
Senorx, Inc. |
Marker or filler forming fluid
|
CN1822816A
(zh)
*
|
2003-05-30 |
2006-08-23 |
阿尔萨公司 |
可植入的弹性体储库组合物、其用途以及制备方法
|
US20070184084A1
(en)
*
|
2003-05-30 |
2007-08-09 |
Guohua Chen |
Implantable elastomeric caprolactone depot compositions and uses thereof
|
US20060188573A1
(en)
*
|
2003-06-10 |
2006-08-24 |
Anna Imberg |
Composite materials and particles
|
US20050048123A1
(en)
|
2003-06-26 |
2005-03-03 |
Control Delivery System, Inc. |
In situ gelling drug delivery system
|
US8226715B2
(en)
|
2003-06-30 |
2012-07-24 |
Depuy Mitek, Inc. |
Scaffold for connective tissue repair
|
JP2007528853A
(ja)
*
|
2003-07-08 |
2007-10-18 |
テファ, インコーポレイテッド |
徐放性薬物送達のためのポリ−4−ヒドロキシブチレートマトリックス
|
CA2915574C
(en)
|
2003-07-18 |
2017-02-07 |
Oakwood Laboratories, L.L.C. |
Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
|
US10583220B2
(en)
|
2003-08-11 |
2020-03-10 |
DePuy Synthes Products, Inc. |
Method and apparatus for resurfacing an articular surface
|
US20060287659A1
(en)
*
|
2003-08-22 |
2006-12-21 |
Tepha, Inc. |
Polyhydroxyalkanoate nerve regeneration devices
|
US7141354B2
(en)
*
|
2003-09-30 |
2006-11-28 |
Dai Nippon Printing Co., Ltd. |
Photo radical generator, photo sensitive resin composition and article
|
US7309232B2
(en)
*
|
2003-10-10 |
2007-12-18 |
Dentigenix Inc. |
Methods for treating dental conditions using tissue scaffolds
|
US20050281879A1
(en)
*
|
2003-11-14 |
2005-12-22 |
Guohua Chen |
Excipients in drug delivery vehicles
|
US20050273002A1
(en)
*
|
2004-06-04 |
2005-12-08 |
Goosen Ryan L |
Multi-mode imaging marker
|
US20050107867A1
(en)
*
|
2003-11-17 |
2005-05-19 |
Taheri Syde A. |
Temporary absorbable venous occlusive stent and superficial vein treatment method
|
US7316822B2
(en)
|
2003-11-26 |
2008-01-08 |
Ethicon, Inc. |
Conformable tissue repair implant capable of injection delivery
|
US8673021B2
(en)
*
|
2003-11-26 |
2014-03-18 |
Depuy Mitek, Llc |
Arthroscopic tissue scaffold delivery device
|
US7901461B2
(en)
|
2003-12-05 |
2011-03-08 |
Ethicon, Inc. |
Viable tissue repair implants and methods of use
|
GB0329654D0
(en)
|
2003-12-23 |
2004-01-28 |
Smith & Nephew |
Tunable segmented polyacetal
|
CA2552241C
(en)
*
|
2003-12-30 |
2013-10-01 |
Durect Corporation |
Co-polymeric devices for controlled release of active agents
|
EP1708734A4
(de)
*
|
2004-01-07 |
2009-06-17 |
Trimeris Inc |
Von hiv gp41 hr2 abgeleitete peptide und deren verwendung in der therapie zur hemmung der übertragung des humanen immundefizienzvirus
|
WO2005070445A2
(en)
*
|
2004-01-13 |
2005-08-04 |
Vasogenix Pharmaceuticals, Inc. |
Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
|
WO2005070444A2
(en)
*
|
2004-01-13 |
2005-08-04 |
Vasogenix Pharmaceuticals, Inc. |
Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
|
EP1703895A2
(de)
*
|
2004-01-13 |
2006-09-27 |
Vasogenix Pharmaceuticals, Inc. |
Zusammensetzung zur cgrp anwendung mit kontrollierter freigabe zur behandlung von kardiovaskulären oder nieren indikationen
|
US20050165487A1
(en)
|
2004-01-28 |
2005-07-28 |
Muhanna Nabil L. |
Artificial intervertebral disc
|
US11395865B2
(en)
|
2004-02-09 |
2022-07-26 |
DePuy Synthes Products, Inc. |
Scaffolds with viable tissue
|
US8048101B2
(en)
|
2004-02-25 |
2011-11-01 |
Femasys Inc. |
Methods and devices for conduit occlusion
|
US9238127B2
(en)
|
2004-02-25 |
2016-01-19 |
Femasys Inc. |
Methods and devices for delivering to conduit
|
US8052669B2
(en)
|
2004-02-25 |
2011-11-08 |
Femasys Inc. |
Methods and devices for delivery of compositions to conduits
|
US8048086B2
(en)
|
2004-02-25 |
2011-11-01 |
Femasys Inc. |
Methods and devices for conduit occlusion
|
CA2558200A1
(en)
*
|
2004-03-02 |
2005-09-15 |
Nanotherapeutics, Inc. |
Compositions for repairing bone and methods for preparing and using such compositions
|
TW200533385A
(en)
*
|
2004-03-03 |
2005-10-16 |
Commw Scient Ind Res Org |
Biocompatible polymer compositions for dual or multi staged curing
|
US20050228433A1
(en)
*
|
2004-03-16 |
2005-10-13 |
Weenna Bucay-Couto |
In situ implant and method of forming same
|
US20050234336A1
(en)
*
|
2004-03-26 |
2005-10-20 |
Beckman Andrew T |
Apparatus and method for marking tissue
|
US20080140185A1
(en)
*
|
2004-04-15 |
2008-06-12 |
University Of Utah Research Foundation |
Biodegradable and Biocompatible Peg-Based Poly(Ester-Urethanes)
|
US7709484B1
(en)
|
2004-04-19 |
2010-05-04 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
US8657881B2
(en)
|
2004-04-20 |
2014-02-25 |
Depuy Mitek, Llc |
Meniscal repair scaffold
|
US8137686B2
(en)
|
2004-04-20 |
2012-03-20 |
Depuy Mitek, Inc. |
Nonwoven tissue scaffold
|
US8221780B2
(en)
|
2004-04-20 |
2012-07-17 |
Depuy Mitek, Inc. |
Nonwoven tissue scaffold
|
US8163030B2
(en)
*
|
2004-05-06 |
2012-04-24 |
Degradable Solutions Ag |
Biocompatible bone implant compositions and methods for repairing a bone defect
|
US20050255045A1
(en)
*
|
2004-05-13 |
2005-11-17 |
Woltering Eugene A |
Surgical marking composition and method
|
US20050281866A1
(en)
*
|
2004-05-24 |
2005-12-22 |
Genzyme Corporation |
Adherent polymeric compositions
|
US8142462B2
(en)
|
2004-05-28 |
2012-03-27 |
Cavitech, Llc |
Instruments and methods for reducing and stabilizing bone fractures
|
US7863406B2
(en)
*
|
2004-06-03 |
2011-01-04 |
Cornell Research Foundation, Inc. |
Unsaturated poly(ester-amide) biomaterials
|
US20110015367A1
(en)
*
|
2004-06-03 |
2011-01-20 |
Cornell University |
Unsaturated poly(ester-amide) and poly(ether ester amide) biomaterials
|
SG173326A1
(en)
|
2004-06-04 |
2011-08-29 |
Camurus Ab |
Liquid depot formulations
|
US20050271727A1
(en)
*
|
2004-06-07 |
2005-12-08 |
Callisyn Pharmaceuticals, Inc. |
Biodegradable and biocompatible crosslinked polymer hydrogel prepared from PVA and/or PEG macromer mixtures
|
EP1604693A1
(de)
|
2004-06-09 |
2005-12-14 |
Scil Technology GmbH |
In-situ hergestelltes Gerüst, dessen Herstellungsverfahren und dessen Verwendung
|
WO2006004774A2
(en)
*
|
2004-06-28 |
2006-01-12 |
Stanford University |
Laulimalide analogues as therapeutic agents
|
CA2572603C
(en)
*
|
2004-06-29 |
2013-01-15 |
Biocure, Inc. |
Spinal disc nucleus pulposus implant
|
EP1768617A4
(de)
|
2004-06-29 |
2011-08-10 |
Spine Wave Inc |
Verfahren zur behandlung von defekten und verletzungen der bandscheibe
|
AU2005333515B2
(en)
|
2004-07-09 |
2012-05-10 |
Arizona Board Of Regents, Acting On Behalf Of The University Of Arizona |
Wortmannin analogs and methods of using same in combination with chemotherapeutic agents
|
WO2006017347A2
(en)
*
|
2004-07-12 |
2006-02-16 |
Allergan, Inc. |
Opthalmic compositions and methods for treating ophthalmic conditions
|
PT1629844E
(pt)
|
2004-07-13 |
2007-10-17 |
Bayer Schering Pharma Oy |
Sistema de distribuição a longo prazo com distribuição súbita inicial controlada
|
EP2221069B1
(de)
*
|
2004-08-03 |
2012-05-09 |
Tepha, Inc. |
Polyhydroxyalkanoate Nähte die sich nicht aufrollen
|
AU2005271242B9
(en)
*
|
2004-08-12 |
2012-04-12 |
Foresee Pharmaceuticals Co., Ltd. |
Pharmaceutical compositions for controlled release delivery of biologically active compounds
|
US20060039949A1
(en)
*
|
2004-08-20 |
2006-02-23 |
Nycz Jeffrey H |
Acetabular cup with controlled release of an osteoinductive formulation
|
US7919112B2
(en)
*
|
2004-08-26 |
2011-04-05 |
Pathak Holdings, Llc |
Implantable tissue compositions and method
|
WO2006026504A2
(en)
*
|
2004-08-27 |
2006-03-09 |
Spherics, Inc. |
Mucoadhesive oral formulations of high permeability, high solubility drugs
|
US20060052822A1
(en)
*
|
2004-08-31 |
2006-03-09 |
Mirizzi Michael S |
Apparatus and material composition for permanent occlusion of a hollow anatomical structure
|
US20060045902A1
(en)
*
|
2004-09-01 |
2006-03-02 |
Serbousek Jon C |
Polymeric wrap for in vivo delivery of osteoinductive formulations
|
US8440215B2
(en)
*
|
2004-09-03 |
2013-05-14 |
Ethicon, Inc. |
Absorbable polymer formulations
|
US7754233B2
(en)
*
|
2004-09-03 |
2010-07-13 |
Ethicon, Inc. |
Method of preventing post-operative surgical adhesion
|
US20060057184A1
(en)
*
|
2004-09-16 |
2006-03-16 |
Nycz Jeffrey H |
Process to treat avascular necrosis (AVN) with osteoinductive materials
|
LT2767292T
(lt)
|
2004-09-17 |
2016-12-12 |
Durect Corporation |
Palaikomosios vietinės anestezijos mišinys su saib
|
US20060074422A1
(en)
*
|
2004-09-27 |
2006-04-06 |
Story Brooks J |
Suture anchor and void filler combination
|
US9012506B2
(en)
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
WO2006036967A1
(en)
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Solubilizing a drug for use in a coating
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
US9801982B2
(en)
|
2004-09-28 |
2017-10-31 |
Atrium Medical Corporation |
Implantable barrier device
|
US8962023B2
(en)
|
2004-09-28 |
2015-02-24 |
Atrium Medical Corporation |
UV cured gel and method of making
|
US8313763B2
(en)
*
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
AU2005294382A1
(en)
*
|
2004-10-04 |
2006-04-20 |
Qlt Usa, Inc. |
Ocular delivery of polymeric delivery formulations
|
US20210299056A9
(en)
|
2004-10-25 |
2021-09-30 |
Varian Medical Systems, Inc. |
Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
|
BRPI0518383A2
(pt)
|
2004-10-25 |
2008-11-18 |
Polyzenix Gmbh |
partÍculas polimÉricas carregÁveis para aplicaÇÕes terepÊuticas e/ou diagnàstico e mÉtodos para preparar e usar as mesmas
|
US9107850B2
(en)
*
|
2004-10-25 |
2015-08-18 |
Celonova Biosciences, Inc. |
Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
|
US9114162B2
(en)
|
2004-10-25 |
2015-08-25 |
Celonova Biosciences, Inc. |
Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
|
US8173148B2
(en)
*
|
2004-11-10 |
2012-05-08 |
Tolmar Therapeutics, Inc. |
Stabilized polymeric delivery system comprising a water-insoluble polymer and an organic liquid
|
AR052155A1
(es)
*
|
2004-12-14 |
2007-03-07 |
Novartis Ag |
Compuestos organicos
|
US20090292013A1
(en)
*
|
2004-12-14 |
2009-11-26 |
Caroline Sautter |
In-Situ Forming Implant for Animals
|
US20060282169A1
(en)
*
|
2004-12-17 |
2006-12-14 |
Felt Jeffrey C |
System and method for upper extremity joint arthroplasty
|
US20060141040A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
US20060142234A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
KR20070101239A
(ko)
*
|
2005-01-08 |
2007-10-16 |
알파스파인, 아이엔씨. |
모듈러 디스크 장치
|
US7968668B2
(en)
|
2005-01-10 |
2011-06-28 |
Ethicon Inc. |
Diisocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant
|
US20060153796A1
(en)
*
|
2005-01-10 |
2006-07-13 |
Fitz Benjamin D |
Diisocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant
|
US8470954B2
(en)
|
2005-01-10 |
2013-06-25 |
Ethicon, Inc. |
Diisocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant
|
US7728097B2
(en)
*
|
2005-01-10 |
2010-06-01 |
Ethicon, Inc. |
Method of making a diisocyanate terminated macromer
|
US20070167617A1
(en)
*
|
2006-01-17 |
2007-07-19 |
Fitz Benjamin D |
Method of making a diisocyanate terminated macromer
|
ES2343641T3
(es)
|
2005-01-14 |
2010-08-05 |
Camurus Ab |
Formulaciones bioadhesivas topicas.
|
US9649382B2
(en)
|
2005-01-14 |
2017-05-16 |
Camurus Ab |
Topical bioadhesive formulations
|
ATE501710T1
(de)
*
|
2005-01-14 |
2011-04-15 |
Camurus Ab |
Somatostatin-analog-formulierungen
|
EP1843751B1
(de)
|
2005-01-21 |
2020-09-30 |
Camurus Ab |
Pharmazeutische lipid-zusammensetzungen
|
US7972354B2
(en)
|
2005-01-25 |
2011-07-05 |
Tyco Healthcare Group Lp |
Method and apparatus for impeding migration of an implanted occlusive structure
|
ES2362221T3
(es)
*
|
2005-01-28 |
2011-06-29 |
Tepha, Inc. |
Embolización con partículas poli-4-hidroxibutirato.
|
US8137664B2
(en)
*
|
2005-02-02 |
2012-03-20 |
Sdgi Holdings, Inc. |
Method and kit for repairing a defect in bone
|
US7611494B2
(en)
*
|
2005-02-08 |
2009-11-03 |
Confluent Surgical, Inc. |
Spray for fluent materials
|
AU2006213822B2
(en)
*
|
2005-02-09 |
2011-05-26 |
Covidien Lp |
Synthetic sealants
|
EP1848489A2
(de)
*
|
2005-02-16 |
2007-10-31 |
Cytori Therapeutics, Inc. |
Resorbierbare hohle vorrichtungen zur implantation und freisetzung therapeutischer mittel
|
CA2498623A1
(en)
*
|
2005-02-18 |
2006-08-18 |
Qlt Inc. |
Treatment of onychomycosis
|
US20060189958A1
(en)
*
|
2005-02-21 |
2006-08-24 |
Talton James D |
Inverted cannula for use in reconstituting dry material in syringes
|
US7851189B2
(en)
*
|
2005-03-07 |
2010-12-14 |
Boston Scientific Scimed, Inc. |
Microencapsulated compositions for endoluminal tissue engineering
|
US7267690B2
(en)
*
|
2005-03-09 |
2007-09-11 |
Vertebral Technologies, Inc. |
Interlocked modular disc nucleus prosthesis
|
US20060222596A1
(en)
|
2005-04-01 |
2006-10-05 |
Trivascular, Inc. |
Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
|
US10357328B2
(en)
|
2005-04-20 |
2019-07-23 |
Bard Peripheral Vascular, Inc. and Bard Shannon Limited |
Marking device with retractable cannula
|
US20060242562A1
(en)
*
|
2005-04-22 |
2006-10-26 |
Microsoft Corporation |
Embedded method for embedded interaction code array
|
US8414907B2
(en)
|
2005-04-28 |
2013-04-09 |
Warsaw Orthopedic, Inc. |
Coatings on medical implants to guide soft tissue healing
|
US9119901B2
(en)
*
|
2005-04-28 |
2015-09-01 |
Warsaw Orthopedic, Inc. |
Surface treatments for promoting selective tissue attachment to medical impants
|
WO2006125074A1
(en)
*
|
2005-05-17 |
2006-11-23 |
Brown University Research Foundation |
Drug delivery formulations for targeted delivery
|
EP1890712A4
(de)
*
|
2005-05-31 |
2012-08-15 |
Warsaw Orthopedic Inc |
Zusammensetzungen und verfahren zur behandlung von schmerzen
|
PL1888031T3
(pl)
*
|
2005-06-06 |
2013-04-30 |
Camurus Ab |
Preparaty analogu glp-1
|
US7727235B2
(en)
*
|
2005-06-29 |
2010-06-01 |
Ethicon, Inc. |
Medical fixation devices with improved torsional drive head
|
WO2007009683A2
(en)
*
|
2005-07-15 |
2007-01-25 |
Laboratorios Del Dr.Esteve, S.A. |
Pharmaceutical formulations of substituted pyrazoline compounds
|
EP1743638A1
(de)
|
2005-07-15 |
2007-01-17 |
Laboratorios Del Dr. Esteve, S.A. |
Pharmazeutische Formulierungen von substituierten Pyrazolinderivaten
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
EP1909774A2
(de)
*
|
2005-08-04 |
2008-04-16 |
Angiotech International Ag |
Blockc-polymerzusammensetzung und verwendungen davon
|
JP2009504269A
(ja)
|
2005-08-08 |
2009-02-05 |
サイティック コーポレーション |
膨張させて皮膚の間隔をとる方法
|
WO2007020432A2
(en)
*
|
2005-08-18 |
2007-02-22 |
Smith & Nephew, Plc |
High strength devices and composites
|
US8362086B2
(en)
|
2005-08-19 |
2013-01-29 |
Merial Limited |
Long acting injectable formulations
|
GB0517674D0
(en)
*
|
2005-08-31 |
2005-10-05 |
Astrazeneca Ab |
Formulation
|
GB0517673D0
(en)
*
|
2005-08-31 |
2005-10-05 |
Astrazeneca Ab |
Formulation
|
ES2478623T3
(es)
*
|
2005-09-06 |
2014-07-22 |
Theraject, Inc. |
Perforador de solución sólido que contiene partículas de medicamentos y/o partículas adsorbentes de medicamentos
|
US9278161B2
(en)
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
US8574627B2
(en)
|
2006-11-06 |
2013-11-05 |
Atrium Medical Corporation |
Coated surgical mesh
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
US10174070B2
(en)
|
2005-09-30 |
2019-01-08 |
Endece Llc |
6-substituted estradiol derivatives and methods of use
|
US8052658B2
(en)
|
2005-10-07 |
2011-11-08 |
Bard Peripheral Vascular, Inc. |
Drug-eluting tissue marker
|
JP2009511190A
(ja)
|
2005-10-13 |
2009-03-19 |
エンドルミナル セラピューティクス, インコーポレイテッド |
チャネルによる壁内治療
|
NZ568204A
(en)
|
2005-10-13 |
2012-01-12 |
Human Genome Sciences Inc |
Methods and compositions for use in treatment of patients with autoantibody positive diseases
|
EP1933991A4
(de)
|
2005-10-15 |
2012-05-02 |
Atrium Medical Corp |
Hydrophobe vernetzte gele für bioabsorbierbare arzneimittelträgerüberzüge
|
US20070100449A1
(en)
*
|
2005-10-31 |
2007-05-03 |
O'neil Michael |
Injectable soft tissue fixation technique
|
CA2628313A1
(en)
*
|
2005-11-04 |
2007-05-31 |
Bio Syntech Canada Inc. |
Composition and method for efficient delivery of nucleic acids to cells using chitosan
|
US20070110788A1
(en)
*
|
2005-11-14 |
2007-05-17 |
Hissong James B |
Injectable formulation capable of forming a drug-releasing device
|
US7754826B1
(en)
*
|
2005-11-15 |
2010-07-13 |
Clemson University |
Copolymers from lactide
|
CA2629300C
(en)
|
2005-11-17 |
2014-07-08 |
Zogenix, Inc. |
Delivery of viscous formulations by needle-free injection
|
US20070149641A1
(en)
*
|
2005-12-28 |
2007-06-28 |
Goupil Dennis W |
Injectable bone cement
|
CN101400363B
(zh)
|
2006-01-18 |
2012-08-29 |
昌达生物科技公司 |
具有增强的稳定性的药物组合物
|
US7456251B2
(en)
|
2006-02-02 |
2008-11-25 |
Trimeris, Inc. |
HIV fusion inhibitor peptides with improved biological properties
|
US20080230001A1
(en)
*
|
2006-02-23 |
2008-09-25 |
Meadwestvaco Corporation |
Method for treating a substrate
|
WO2007103276A2
(en)
|
2006-03-03 |
2007-09-13 |
Smith & Nephew, Inc. |
Systems and methods for delivering a medicament
|
US8795709B2
(en)
|
2006-03-29 |
2014-08-05 |
Incept Llc |
Superabsorbent, freeze dried hydrogels for medical applications
|
BRPI0709427A2
(pt)
*
|
2006-03-30 |
2011-07-12 |
Palatin Technologies Inc |
"construto cìclico, composição farmacêutica e uso de um composto
|
CA2647146A1
(en)
*
|
2006-03-30 |
2007-10-11 |
Palatin Technologies, Inc. |
Linear natriuretic peptide constructs
|
US8580746B2
(en)
|
2006-03-30 |
2013-11-12 |
Palatin Technologies, Inc. |
Amide linkage cyclic natriuretic peptide constructs
|
US9017361B2
(en)
|
2006-04-20 |
2015-04-28 |
Covidien Lp |
Occlusive implant and methods for hollow anatomical structure
|
US7993675B2
(en)
*
|
2006-05-10 |
2011-08-09 |
Medtronic Xomed, Inc. |
Solvating system and sealant for medical use in the sinuses and nasal passages
|
US7959943B2
(en)
*
|
2006-05-10 |
2011-06-14 |
Medtronics Xomed, Inc. |
Solvating system and sealant for medical use in the middle or inner ear
|
US7976873B2
(en)
*
|
2006-05-10 |
2011-07-12 |
Medtronic Xomed, Inc. |
Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
|
CN101534917A
(zh)
|
2006-05-22 |
2009-09-16 |
纽约市哥伦比亚大学理事会 |
采用萃取流体排出流过滤的微流无膜交换系统和方法
|
US7872068B2
(en)
*
|
2006-05-30 |
2011-01-18 |
Incept Llc |
Materials formable in situ within a medical device
|
EP1872807A1
(de)
*
|
2006-06-30 |
2008-01-02 |
Scil Technology GmbH |
Durch Polymere gegen Abbau stabilisiertes Biomaterial
|
KR20140109509A
(ko)
*
|
2006-07-11 |
2014-09-15 |
큐피에스 엘엘씨 |
펩타이드의 지속 방출 전달을 위한 의약 조성물
|
EP3009477B1
(de)
|
2006-07-20 |
2024-01-24 |
Orbusneich Medical Pte. Ltd |
Bioresorbierbare polymerzusammensetzung für eine medizinische vorrichtung
|
US20090171198A1
(en)
*
|
2006-08-04 |
2009-07-02 |
Jones Michael L |
Powdered marker
|
US7945307B2
(en)
*
|
2006-08-04 |
2011-05-17 |
Senorx, Inc. |
Marker delivery system with obturator
|
US7947758B2
(en)
*
|
2006-08-09 |
2011-05-24 |
Ethicon, Inc. |
Moisture activated latent curing adhesive or sealant
|
US8129445B2
(en)
*
|
2006-08-09 |
2012-03-06 |
Ethicon, Inc. |
Moisture activated latent curing adhesive or sealant
|
US7834017B2
(en)
|
2006-08-11 |
2010-11-16 |
Palatin Technologies, Inc. |
Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
|
US20080058954A1
(en)
*
|
2006-08-22 |
2008-03-06 |
Hai Trieu |
Methods of treating spinal injuries using injectable flowable compositions comprising organic materials
|
WO2008027557A2
(en)
*
|
2006-08-31 |
2008-03-06 |
Spherics, Inc. |
Topiramate compositions and methods of enhancing its bioavailability
|
US8076448B2
(en)
*
|
2006-10-11 |
2011-12-13 |
Tolmar Therapeutics, Inc. |
Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
|
US7959942B2
(en)
|
2006-10-20 |
2011-06-14 |
Orbusneich Medical, Inc. |
Bioabsorbable medical device with coating
|
EP2073754A4
(de)
|
2006-10-20 |
2012-09-26 |
Orbusneich Medical Inc |
Bioresorbierbare polymerzusammensetzung und hintergrund für eine medizinische vorrichtung
|
US8064987B2
(en)
|
2006-10-23 |
2011-11-22 |
C. R. Bard, Inc. |
Breast marker
|
US8268347B1
(en)
|
2006-10-24 |
2012-09-18 |
Aradigm Corporation |
Dual action, inhaled formulations providing both an immediate and sustained release profile
|
US20080102097A1
(en)
*
|
2006-10-31 |
2008-05-01 |
Zanella John M |
Device and method for treating osteolysis using a drug depot to deliver an anti-inflammatory agent
|
US8337883B2
(en)
|
2006-11-03 |
2012-12-25 |
Durect Corporation |
Transdermal delivery systems
|
US9492596B2
(en)
|
2006-11-06 |
2016-11-15 |
Atrium Medical Corporation |
Barrier layer with underlying medical device and one or more reinforcing support structures
|
MX2009001711A
(es)
|
2006-11-17 |
2009-05-08 |
Supernus Pharmaceuticals Inc |
Formulaciones de liberacion sostenida de topiramato.
|
US9737414B2
(en)
|
2006-11-21 |
2017-08-22 |
Vertebral Technologies, Inc. |
Methods and apparatus for minimally invasive modular interbody fusion devices
|
CA2679365C
(en)
|
2006-11-30 |
2016-05-03 |
Smith & Nephew, Inc. |
Fiber reinforced composite material
|
US7943683B2
(en)
*
|
2006-12-01 |
2011-05-17 |
Tepha, Inc. |
Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
|
EP3542748B1
(de)
*
|
2006-12-12 |
2023-08-16 |
C. R. Bard, Inc. |
Gewebemarker mit mehreren bildgebungsmodi
|
US20080140106A1
(en)
*
|
2006-12-12 |
2008-06-12 |
Kimberly-Clark Worldwide, Inc. |
Enhanced cuff sealing for endotracheal tubes
|
ES2432572T3
(es)
*
|
2006-12-18 |
2013-12-04 |
C.R. Bard, Inc. |
Marcador de biopsia con propiedades de obtención de imágenes generadas in situ
|
US8088095B2
(en)
*
|
2007-02-08 |
2012-01-03 |
Medtronic Xomed, Inc. |
Polymeric sealant for medical use
|
PT2115029E
(pt)
|
2007-02-15 |
2015-10-26 |
Tolmar Therapeutics Inc |
Poli-(lactido/glicolido) de efeito de libertação imediata reduzido e métodos de produção de polímeros
|
US20090227689A1
(en)
|
2007-03-05 |
2009-09-10 |
Bennett Steven L |
Low-Swelling Biocompatible Hydrogels
|
US20090227981A1
(en)
|
2007-03-05 |
2009-09-10 |
Bennett Steven L |
Low-Swelling Biocompatible Hydrogels
|
US20080220047A1
(en)
|
2007-03-05 |
2008-09-11 |
Sawhney Amarpreet S |
Low-swelling biocompatible hydrogels
|
KR20100016142A
(ko)
*
|
2007-04-03 |
2010-02-12 |
트라이머리스, 인코퍼레이티드 |
항바이러스 펩티드 치료제 전달용 신규 제제
|
JP5416090B2
(ja)
*
|
2007-04-18 |
2014-02-12 |
スミス アンド ネフュー ピーエルシー |
形状記憶ポリマーの膨張成形
|
US9770534B2
(en)
*
|
2007-04-19 |
2017-09-26 |
Smith & Nephew, Inc. |
Graft fixation
|
EP2142227B1
(de)
*
|
2007-04-19 |
2012-02-29 |
Smith & Nephew, Inc. |
Multimodale formgedächtnis-polymere
|
CA2684759C
(en)
|
2007-05-15 |
2015-11-03 |
Barry M. Fell |
Surgically implantable knee prosthesis with captured keel
|
DK2167039T3
(en)
|
2007-05-18 |
2017-01-09 |
Durect Corp |
Improved depot formulations
|
CA2692002A1
(en)
|
2007-05-21 |
2008-11-27 |
Aoi Medical Inc. |
Articulating cavitation device
|
MX337286B
(es)
|
2007-05-25 |
2016-02-22 |
Indivior Uk Ltd |
Formulaciones de transferencia sostenida de compuestos de risperidona.
|
CN201075472Y
(zh)
*
|
2007-05-28 |
2008-06-18 |
富士康(昆山)电脑接插件有限公司 |
电连接器
|
WO2008144881A1
(en)
*
|
2007-05-28 |
2008-12-04 |
Genesis Group Inc. |
Biodegradable elastomers prepared by the condensation of an organic di-, tri- or tetra-carboxylic acid and an organic diol
|
GB0711656D0
(en)
|
2007-06-15 |
2007-07-25 |
Camurus Ab |
Formulations
|
US9125807B2
(en)
|
2007-07-09 |
2015-09-08 |
Incept Llc |
Adhesive hydrogels for ophthalmic drug delivery
|
US20090149569A1
(en)
*
|
2007-07-19 |
2009-06-11 |
Shastri V Prasad |
Surface engineering of tissue graft materials for enhanced porosity and cell adhesion
|
US7850453B2
(en)
*
|
2007-08-08 |
2010-12-14 |
Coll Partners Ltd. |
Reshapable device for fixation at a dental site
|
US8067028B2
(en)
*
|
2007-08-13 |
2011-11-29 |
Confluent Surgical Inc. |
Drug delivery device
|
GB0716385D0
(en)
|
2007-08-22 |
2007-10-03 |
Camurus Ab |
Formulations
|
SG184728A1
(en)
*
|
2007-09-07 |
2012-10-30 |
Quadra Logic Tech Inc |
Lacrimal implant detection
|
MX2010003179A
(es)
*
|
2007-09-25 |
2010-04-30 |
Trimeris Inc |
Metodos de sintesis para peptidos anti-vih terapeuticos.
|
US20090088723A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Accessclosure, Inc. |
Apparatus and methods for treating pseudoaneurysms
|
US8703119B2
(en)
*
|
2007-10-05 |
2014-04-22 |
Polygene Ltd. |
Injectable biodegradable polymer compositions for soft tissue repair and augmentation
|
EP2052716B1
(de)
|
2007-10-24 |
2014-12-31 |
Camurus AB |
Formulierungen mit gesteuerter Freisetzung
|
US20090110738A1
(en)
*
|
2007-10-26 |
2009-04-30 |
Celonova Biosciences, Inc. |
Loadable Polymeric Particles for Cosmetic and Reconstructive Tissue Augmentation Applications and Methods of Preparing and Using the Same
|
US20090111763A1
(en)
*
|
2007-10-26 |
2009-04-30 |
Celonova Biosciences, Inc. |
Loadable polymeric particles for bone augmentation and methods of preparing and using the same
|
US20090110730A1
(en)
*
|
2007-10-30 |
2009-04-30 |
Celonova Biosciences, Inc. |
Loadable Polymeric Particles for Marking or Masking Individuals and Methods of Preparing and Using the Same
|
US20090110731A1
(en)
*
|
2007-10-30 |
2009-04-30 |
Celonova Biosciences, Inc. |
Loadable Polymeric Microparticles for Therapeutic Use in Alopecia and Methods of Preparing and Using the Same
|
CA2705520C
(en)
*
|
2007-11-13 |
2016-06-28 |
Surmodics Pharmaceuticals, Inc. |
Viscous terpolymers as drug delivery platform
|
AT506168B1
(de)
*
|
2007-11-23 |
2012-02-15 |
Univ Wien Tech |
Verwendung von zusammensetzungen zur herstellung biologisch abbaubarer, bioverträglicher, vernetzter polymere auf basis von polyvinylalkohol
|
CA2706658A1
(en)
|
2007-12-06 |
2009-06-18 |
Durect Corporation |
Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition
|
CA2710515A1
(en)
*
|
2007-12-28 |
2009-07-09 |
Khashayar Kevin Neshat |
Controlled release local anesthetic for post dental surgery and method of use
|
US20090181068A1
(en)
*
|
2008-01-14 |
2009-07-16 |
Dunn Richard L |
Low Viscosity Liquid Polymeric Delivery System
|
WO2009097559A1
(en)
|
2008-01-30 |
2009-08-06 |
Histogen, Inc. |
Extracellular matrix compositions
|
US8311610B2
(en)
*
|
2008-01-31 |
2012-11-13 |
C. R. Bard, Inc. |
Biopsy tissue marker
|
MX2010008591A
(es)
|
2008-02-04 |
2010-08-30 |
Univ Columbia |
Dispositivos, sistemas y metodos de separacion de fluidos.
|
US20090202642A1
(en)
*
|
2008-02-08 |
2009-08-13 |
Xiao Huang |
Drug Delivery System Comprising Microparticles and Gelation System
|
US9107815B2
(en)
|
2008-02-22 |
2015-08-18 |
Allergan, Inc. |
Sustained release poloxamer containing pharmaceutical compositions
|
US8071663B2
(en)
*
|
2008-02-29 |
2011-12-06 |
Ethicon, Inc. |
Medically acceptable formulation of a diisocyanate terminated macromer for use as an internal adhesive or sealant
|
US8324292B2
(en)
*
|
2008-02-29 |
2012-12-04 |
Ethicon, Inc. |
Medically acceptable formulation of a diisocyanate terminated macromer for use as an internal adhesive or sealant
|
US8745133B2
(en)
*
|
2008-03-28 |
2014-06-03 |
Yahoo! Inc. |
System and method for optimizing the storage of data
|
AU2009239429B2
(en)
|
2008-04-21 |
2013-08-29 |
Otonomy, Inc. |
Auris formulations for treating otic diseases and conditions
|
ES2563061T3
(es)
|
2008-04-28 |
2016-03-10 |
Zogenix, Inc. |
Nuevas formulaciones para el tratamiento de la migraña
|
KR101464983B1
(ko)
*
|
2008-05-01 |
2014-11-25 |
스파인셀 프러프라이어테리 리미티드 |
조직 보형물의 형성 및 삽입기구 및 그의 시스템 및 방법
|
JP5551685B2
(ja)
|
2008-05-14 |
2014-07-16 |
オトノミ―,インク. |
制御放出型コルチコステロイド組成物、および耳の疾患を処置する方法
|
KR101383285B1
(ko)
*
|
2008-05-21 |
2014-04-08 |
테라젝트, 인코포레이티드 |
고용체 퍼포레이터 패치의 제조 방법 및 그 사용
|
CA2726763A1
(en)
*
|
2008-06-03 |
2009-12-10 |
Tolmar Therapeutics, Inc. |
Controlled release copolymer formulation with improved release kinetics
|
US9486531B2
(en)
*
|
2008-06-03 |
2016-11-08 |
Indivior Uk Limited |
Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system
|
EP2303254B1
(de)
|
2008-06-12 |
2019-10-30 |
Medtronic Xomed, Inc. |
Produkt zur behandlung von chronischen wunden mit einem extrazellulären polymer-substanz-solvatisierungssystem
|
EP2326304A2
(de)
|
2008-07-17 |
2011-06-01 |
Merial Limited |
Verfahren zur verbesserung der stabilität von polyorthoestern und ihren formulierungen
|
US8318817B2
(en)
|
2008-07-21 |
2012-11-27 |
Otonomy, Inc. |
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
|
EP2306975A4
(de)
|
2008-07-21 |
2012-10-31 |
Otonomy Inc |
Zusammensetzungen mit gesteuerter freisetzung zur modulierung der ohrenstruktur und des angeborenen immunsystems sowie verfahren zur behandlung von ohrerkrankungen
|
US8784870B2
(en)
|
2008-07-21 |
2014-07-22 |
Otonomy, Inc. |
Controlled release compositions for modulating free-radical induced damage and methods of use thereof
|
JP5518066B2
(ja)
|
2008-07-30 |
2014-06-11 |
メシンセス リミテッド |
前胃細胞外マトリックス由来の組織スキャフォールド
|
US9271706B2
(en)
|
2008-08-12 |
2016-03-01 |
Covidien Lp |
Medical device for wound closure and method of use
|
AU2009282868B2
(en)
|
2008-08-19 |
2013-09-05 |
Covidien Lp |
Detachable tip microcatheter
|
GB0815435D0
(en)
|
2008-08-22 |
2008-10-01 |
Camurus Ab |
Formulations
|
US9327061B2
(en)
|
2008-09-23 |
2016-05-03 |
Senorx, Inc. |
Porous bioabsorbable implant
|
EP2341923A2
(de)
*
|
2008-09-26 |
2011-07-13 |
Saumya Sharma |
Pharmazeutische zusammensetzung mit coenzym q10
|
US10070888B2
(en)
|
2008-10-03 |
2018-09-11 |
Femasys, Inc. |
Methods and devices for sonographic imaging
|
US9554826B2
(en)
|
2008-10-03 |
2017-01-31 |
Femasys, Inc. |
Contrast agent injection system for sonographic imaging
|
US9889230B2
(en)
*
|
2008-10-17 |
2018-02-13 |
Covidien Lp |
Hemostatic implant
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
CA2780624A1
(en)
|
2008-11-11 |
2010-05-20 |
Signum Biosciences, Inc. |
Isoprenyl derivatives useful as agents to modulate inflammation
|
US8822546B2
(en)
*
|
2008-12-01 |
2014-09-02 |
Medtronic, Inc. |
Flowable pharmaceutical depot
|
WO2010065799A2
(en)
|
2008-12-04 |
2010-06-10 |
Palatin Technologies, Inc. |
Amine substituted piperidine melanocortin receptor-specific compounds
|
WO2010065802A2
(en)
|
2008-12-04 |
2010-06-10 |
Palatin Technologies, Inc. |
Substituted pyrrolidine or imidazolidine melanocortin receptor-specific compounds
|
WO2010065801A1
(en)
|
2008-12-04 |
2010-06-10 |
Palatin Technologies, Inc. |
Amine substituted piperazine melanocortin receptor-specific compounds
|
US9415197B2
(en)
*
|
2008-12-23 |
2016-08-16 |
Surmodics, Inc. |
Implantable suction cup composites and implants comprising same
|
US9480643B2
(en)
|
2008-12-23 |
2016-11-01 |
Surmodics Pharmaceuticals, Inc. |
Implantable composites and implants comprising same
|
US8951546B2
(en)
|
2008-12-23 |
2015-02-10 |
Surmodics Pharmaceuticals, Inc. |
Flexible implantable composites and implants comprising same
|
US8974808B2
(en)
|
2008-12-23 |
2015-03-10 |
Surmodics, Inc. |
Elastic implantable composites and implants comprising same
|
US20100168807A1
(en)
*
|
2008-12-23 |
2010-07-01 |
Burton Kevin W |
Bioactive terpolymer compositions and methods of making and using same
|
US8670818B2
(en)
|
2008-12-30 |
2014-03-11 |
C. R. Bard, Inc. |
Marker delivery device for tissue marker placement
|
US8469779B1
(en)
|
2009-01-02 |
2013-06-25 |
Lifecell Corporation |
Method for debristling animal skin
|
WO2010079340A2
(en)
|
2009-01-08 |
2010-07-15 |
Eisai R & D Management Co., Ltd. |
Assay
|
EP2210589B1
(de)
|
2009-01-22 |
2015-05-06 |
Ludwig-Maximilians-Universität München |
Vesikuläre Phospholipid-Gele mit proteinösen Substanzen
|
US20100204570A1
(en)
*
|
2009-02-06 |
2010-08-12 |
Paul Lubock |
Anchor markers
|
WO2010093993A2
(en)
|
2009-02-12 |
2010-08-19 |
Human Genome Sciences, Inc. |
Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance
|
US8409606B2
(en)
*
|
2009-02-12 |
2013-04-02 |
Incept, Llc |
Drug delivery through hydrogel plugs
|
WO2010094032A2
(en)
|
2009-02-16 |
2010-08-19 |
Aoi Medical Inc. |
Trauma nail accumulator
|
EP2223707B1
(de)
*
|
2009-02-26 |
2014-04-09 |
New Dent AG |
Implantatsystem und Knochenimplantat
|
US8383140B2
(en)
*
|
2009-04-03 |
2013-02-26 |
Poly-Med, Inc. |
Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions
|
WO2010129258A2
(en)
|
2009-04-27 |
2010-11-11 |
Mallinckrodt Inc. |
Tissue sealant compositions, vascular closure devices, and uses thereof
|
JP5684239B2
(ja)
*
|
2009-05-04 |
2015-03-11 |
インセプト・リミテッド・ライアビリティ・カンパニーIncept Llc |
軌道および穿刺部閉鎖用の生体材料
|
JP5805632B2
(ja)
|
2009-06-08 |
2015-11-04 |
パラティン テクノロジーズ, インコーポレイテッドPalatin Technologies, Inc. |
メラノコルチン受容体に特異的なペプチド
|
US20120108514A1
(en)
|
2009-07-09 |
2012-05-03 |
University Of Iowa Research Foundation |
Long acting atrial natriuretic peptide (la-anp) and methods for use thereof
|
US20110015672A1
(en)
*
|
2009-07-17 |
2011-01-20 |
Tyco Healthcare Group Lp |
Method for Coating a Medical Device
|
US9200112B2
(en)
|
2009-08-10 |
2015-12-01 |
Ethicon, Inc. |
Semi-crystalline, fast absorbing polymer formulation
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
FR2949687B1
(fr)
*
|
2009-09-04 |
2011-09-23 |
Sofradim Production |
Tissu avec picots revetus d'un materiau hydrosoluble
|
US8470355B2
(en)
*
|
2009-10-01 |
2013-06-25 |
Covidien Lp |
Mesh implant
|
US8138236B2
(en)
*
|
2009-10-29 |
2012-03-20 |
Ethicon, Inc. |
Solvent-free moisture activated latent curing surgical adhesive or sealant
|
US9044524B2
(en)
*
|
2009-10-30 |
2015-06-02 |
Ethicon, Inc. |
Absorbable polyethylene diglycolate copolymers to reduce microbial adhesion to medical devices and implants
|
AU2010314994B2
(en)
|
2009-11-09 |
2016-10-06 |
Spotlight Technology Partners Llc |
Fragmented hydrogels
|
WO2011057131A1
(en)
|
2009-11-09 |
2011-05-12 |
Spotlight Technology Partners Llc |
Polysaccharide based hydrogels
|
EP2498603B1
(de)
|
2009-11-12 |
2016-07-13 |
Signum Biosciences, Inc. |
Verwendung von antibakteriellen mitteln zur behandlung von epithelbedingten erkrankungen
|
JP5820815B2
(ja)
|
2009-12-15 |
2015-11-24 |
インセプト・リミテッド・ライアビリティ・カンパニーIncept,Llc |
インプラントおよび生体分解性基準マーカー
|
GB0922438D0
(en)
|
2009-12-22 |
2010-02-03 |
Ucl Business Plc |
Agents having tissue generative activity
|
US20110218606A1
(en)
*
|
2010-03-02 |
2011-09-08 |
Medtronic Vascular, Inc. |
Methods for Stabilizing Femoral Vessels
|
US20120130489A1
(en)
*
|
2010-05-19 |
2012-05-24 |
Chernomorsky Ary S |
Methods and apparatus for in situ formation of surgical implants
|
CA2794841C
(en)
|
2010-05-20 |
2021-02-23 |
Ecolab Usa Inc. |
Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof
|
US10350159B2
(en)
|
2010-05-31 |
2019-07-16 |
Laboratories Farmacéuticos Rovi, S.A. |
Paliperidone implant formulation
|
US10285936B2
(en)
|
2010-05-31 |
2019-05-14 |
Laboratorios Farmacéuticos Rovi, S.A. |
Injectable composition with aromatase inhibitor
|
US10335366B2
(en)
|
2010-05-31 |
2019-07-02 |
Laboratorios Farmacéuticos Rovi, S.A. |
Risperidone or paliperidone implant formulation
|
US10881605B2
(en)
|
2010-05-31 |
2021-01-05 |
Laboratorios Farmaceuticos Rovi, S.A. |
Methods for the preparation of injectable depot compositions
|
US10463607B2
(en)
|
2010-05-31 |
2019-11-05 |
Laboratorios Farmaceutics Rofi S.A. |
Antipsychotic Injectable Depot Composition
|
SI2394663T1
(sl)
|
2010-05-31 |
2022-02-28 |
Laboratorios Farmaceuticos Rovi, S.A. |
Sestave za injicirane biološko razgradljive vsadke in situ
|
ES2589106T3
(es)
|
2010-05-31 |
2016-11-10 |
Laboratorios Farmaceuticos Rovi, S.A. |
Composición inyectable antipsicótica de liberación controlada
|
GB2513060B
(en)
|
2010-06-08 |
2015-01-07 |
Rb Pharmaceuticals Ltd |
Microparticle buprenorphine suspension
|
GB2481018B
(en)
|
2010-06-08 |
2015-03-18 |
Rb Pharmaceuticals Ltd |
Injectable flowable composition comprising buprenorphine
|
US9272044B2
(en)
|
2010-06-08 |
2016-03-01 |
Indivior Uk Limited |
Injectable flowable composition buprenorphine
|
WO2011161531A1
(en)
|
2010-06-24 |
2011-12-29 |
Torrent Pharmaceuticals Limited |
Pharmaceutical composition containing goserelin for in-situ implant
|
US9232805B2
(en)
|
2010-06-29 |
2016-01-12 |
Biocure, Inc. |
In-situ forming hydrogel wound dressings containing antimicrobial agents
|
WO2012009707A2
(en)
|
2010-07-16 |
2012-01-19 |
Atrium Medical Corporation |
Composition and methods for altering the rate of hydrolysis of cured oil-based materials
|
EP2611868B1
(de)
|
2010-08-30 |
2020-01-08 |
Surmodics Pharmaceuticals, Inc. |
Biologisch abbaubare terpolymere und terpolymermischungen als haftkleber
|
US8961501B2
(en)
|
2010-09-17 |
2015-02-24 |
Incept, Llc |
Method for applying flowable hydrogels to a cornea
|
GB201016436D0
(en)
|
2010-09-30 |
2010-11-17 |
Q Chip Ltd |
Method of making solid beads
|
GB201016433D0
(en)
|
2010-09-30 |
2010-11-17 |
Q Chip Ltd |
Apparatus and method for making solid beads
|
US11207109B2
(en)
|
2010-10-20 |
2021-12-28 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US20120101593A1
(en)
*
|
2010-10-20 |
2012-04-26 |
BIOS2 Medical, Inc. |
Implantable polymer for bone and vascular lesions
|
US10525168B2
(en)
|
2010-10-20 |
2020-01-07 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US11291483B2
(en)
|
2010-10-20 |
2022-04-05 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants
|
US10525169B2
(en)
|
2010-10-20 |
2020-01-07 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US11058796B2
(en)
|
2010-10-20 |
2021-07-13 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US11484627B2
(en)
|
2010-10-20 |
2022-11-01 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US9414930B2
(en)
*
|
2010-10-26 |
2016-08-16 |
Kyphon SÀRL |
Activatable devices containing a chemonucleolysis agent
|
US8740982B2
(en)
*
|
2010-10-26 |
2014-06-03 |
Kyphon Sarl |
Devices containing a chemonucleolysis agent and methods for treating an intervertebral disc or spinal arachnoiditis
|
CN103491946B
(zh)
|
2010-12-29 |
2016-08-10 |
美蒂森 |
可生物降解的药物释放组合物
|
US9084602B2
(en)
|
2011-01-26 |
2015-07-21 |
Covidien Lp |
Buttress film with hemostatic action for surgical stapling apparatus
|
JP6150734B2
(ja)
|
2011-02-03 |
2017-06-21 |
アレクシオン ファーマシューティカルズ, インコーポレイテッド |
同種移植片の生存を長期化するための抗cd200抗体の使用
|
US9375513B2
(en)
|
2011-04-14 |
2016-06-28 |
Lifecell Corporation |
Regenerative materials
|
US9757388B2
(en)
|
2011-05-13 |
2017-09-12 |
Acerus Pharmaceuticals Srl |
Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
|
US20130040923A1
(en)
|
2011-05-13 |
2013-02-14 |
Trimel Pharmaceuticals Corporation |
Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
AR082266A1
(es)
|
2011-05-13 |
2012-11-28 |
Univ Nac Del Litoral |
Microparticula inyectable de liberacion controlada
|
US20130045958A1
(en)
|
2011-05-13 |
2013-02-21 |
Trimel Pharmaceuticals Corporation |
Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
US8998925B2
(en)
|
2011-06-20 |
2015-04-07 |
Rdc Holdings, Llc |
Fixation system for orthopedic devices
|
WO2012177759A1
(en)
|
2011-06-20 |
2012-12-27 |
Rdc Holdings, Llc |
System and method for repairing joints
|
WO2013003157A1
(en)
|
2011-06-28 |
2013-01-03 |
Yale University |
Cell-free tissued engineered vascular grafts
|
US9089523B2
(en)
|
2011-07-28 |
2015-07-28 |
Lifecell Corporation |
Natural tissue scaffolds as tissue fillers
|
CN103906761B
(zh)
|
2011-08-30 |
2016-12-21 |
梅约医学教育与研究基金会 |
利钠多肽
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
US8586527B2
(en)
|
2011-10-20 |
2013-11-19 |
Jaipal Singh |
Cerivastatin to treat pulmonary disorders
|
CA2856520C
(en)
|
2011-11-23 |
2021-04-06 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
CA3131037A1
(en)
|
2011-11-30 |
2013-06-06 |
Emory University |
Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections
|
AU2012347926B2
(en)
|
2011-12-05 |
2018-03-15 |
Incept, Llc |
Medical organogel processes and compositions
|
BR112014013693B1
(pt)
|
2011-12-05 |
2023-01-31 |
Camurus Ab |
Pré-formulação, e, uso de uma pré-formulação
|
WO2013090682A1
(en)
|
2011-12-14 |
2013-06-20 |
Indicator Systems International, Inc. |
Trisubstituted methyl alcohols and their polymerizable derivatives
|
BR112014014975B1
(pt)
|
2011-12-20 |
2019-06-25 |
Lifecell Corporation |
Produto de tecido, e método para produzir uma composição de tecido
|
ES2729712T3
(es)
|
2011-12-20 |
2019-11-05 |
Lifecell Corp |
Productos de tejido de lámina
|
US9611305B2
(en)
|
2012-01-06 |
2017-04-04 |
Mayo Foundation For Medical Education And Research |
Treating cardiovascular or renal diseases
|
ES2758446T3
(es)
|
2012-01-23 |
2020-05-05 |
Sage Therapeutics Inc |
Formulaciones de esteroides neuroactivos que comprenden un complejo de alopregnanolona y sulfobutil éter beta-ciclodextrina
|
ES2705823T3
(es)
|
2012-01-24 |
2019-03-26 |
Lifecell Corp |
Matrices de tejidos alargadas
|
WO2013130877A1
(en)
|
2012-02-29 |
2013-09-06 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, including the use of composite implants
|
US9534018B2
(en)
|
2012-03-13 |
2017-01-03 |
Tensive Controls Inc. |
Melanocortin analogs having enhanced activity and transport
|
US9510953B2
(en)
|
2012-03-16 |
2016-12-06 |
Vertebral Technologies, Inc. |
Modular segmented disc nucleus implant
|
US8403927B1
(en)
|
2012-04-05 |
2013-03-26 |
William Bruce Shingleton |
Vasectomy devices and methods
|
US8753643B1
(en)
|
2012-04-11 |
2014-06-17 |
Life-Science Innovations, Llc |
Spray dried compositions and methods of use
|
CA2871665A1
(en)
|
2012-04-24 |
2013-10-31 |
Lifecell Corporation |
Flowable tissue matrices
|
NL2008861C2
(en)
*
|
2012-05-23 |
2013-11-26 |
Urogyn B V |
Composition for soft tissue treatment.
|
KR102139080B1
(ko)
|
2012-05-25 |
2020-07-29 |
카무러스 에이비 |
소마토스타틴 수용체 작용제 제형
|
CA2985787A1
(en)
|
2012-06-07 |
2013-12-12 |
Georgia State University Research Foundation, Inc. |
Seca inhibitors and methods of making and using thereof
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US11090338B2
(en)
|
2012-07-13 |
2021-08-17 |
Lifecell Corporation |
Methods for improved treatment of adipose tissue
|
EP2877155B1
(de)
|
2012-07-26 |
2020-10-28 |
Camurus AB |
Opioid-formulierungen
|
SI2887944T1
(sl)
|
2012-08-21 |
2022-02-28 |
Sage Therapeutics, Inc. |
Alopregnanolon za zdravljenje refraktornega epileptičnega statusa
|
CA2885327A1
(en)
|
2012-09-26 |
2014-04-03 |
Lifecell Corporation |
Processed adipose tissue
|
DK2900230T3
(en)
|
2012-09-27 |
2018-11-12 |
Childrens Medical Ct Corp |
RELATIONSHIPS FOR TREATING ADIPOSITAS AND PROCEDURES FOR USING THEREOF
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
EP3659633A1
(de)
|
2013-02-06 |
2020-06-03 |
LifeCell Corporation |
Verfahren für lokalisierte modifizierung von gewebeprodukten
|
EA033537B1
(ru)
|
2013-03-11 |
2019-10-31 |
Durect Corp |
Инъекционная композиция с контролируемым высвобождением, содержащая жидкий носитель с высокой вязкостью
|
US20140308352A1
(en)
|
2013-03-11 |
2014-10-16 |
Zogenix Inc. |
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
|
US10624865B2
(en)
*
|
2013-03-14 |
2020-04-21 |
Pathak Holdings Llc |
Methods, compositions, and devices for drug/live cell microarrays
|
US11744838B2
(en)
|
2013-03-15 |
2023-09-05 |
Acerus Biopharma Inc. |
Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
|
CN105120659A
(zh)
|
2013-03-15 |
2015-12-02 |
度瑞公司 |
用于降低溶解可变性的具有流变改性剂的组合物
|
EP2981305B1
(de)
|
2013-04-04 |
2019-06-12 |
The Arizona Board of Regents on behalf of the University of Arizona |
Materialien, systeme, vorrichtungen und verfahren für endoluminale elektropolymere pflasterung und versiegelung
|
EP3795635A1
(de)
|
2013-05-23 |
2021-03-24 |
206 ORTHO, Inc. |
Vorrichtung zur behandlung von knochenbrüchen und/oder zur stärkung und/oder vermehrung von knochen einschliesslich der bereitstellung und verwendung zusammengesetzter implantate
|
CN105682742A
(zh)
|
2013-08-27 |
2016-06-15 |
奥德纳米有限公司 |
小儿耳部病症的治疗
|
USD715442S1
(en)
|
2013-09-24 |
2014-10-14 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
USD715942S1
(en)
|
2013-09-24 |
2014-10-21 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
USD716451S1
(en)
|
2013-09-24 |
2014-10-28 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
USD716450S1
(en)
|
2013-09-24 |
2014-10-28 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
US9757330B2
(en)
|
2013-10-18 |
2017-09-12 |
Industrial Technology Research Institute |
Recipe for in-situ gel, and implant, drug delivery system formed thereby
|
US9668844B2
(en)
|
2013-11-06 |
2017-06-06 |
Colldent Y.A Ltd |
Device for fixation at a dental site
|
US20160375039A1
(en)
|
2013-11-26 |
2016-12-29 |
The Children's Medical Center Corporation |
Compounds for the treatment of obesity and methods of use thereof
|
US20160303242A1
(en)
|
2013-12-09 |
2016-10-20 |
Durect Corporation |
Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
|
WO2015101625A1
(en)
*
|
2013-12-31 |
2015-07-09 |
Pb&B Sa |
Controlled release fatty acid compositions for use in body reconstruction and body-shaping
|
GB201404139D0
(en)
|
2014-03-10 |
2014-04-23 |
Rb Pharmaceuticals Ltd |
Sustained release buprenorphine solution formulations
|
CN111620830A
(zh)
|
2014-03-14 |
2020-09-04 |
北卡罗来纳大学教堂山分校 |
用于抑制雄性生育力的小分子
|
WO2015153933A1
(en)
|
2014-04-03 |
2015-10-08 |
The Children's Medical Center Corporation |
Hsp90 inhibitors for the treatment of obesity and methods of use thereof
|
MX2016014281A
(es)
|
2014-05-22 |
2017-02-22 |
Therapeuticsmd Inc |
Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
|
US9421199B2
(en)
|
2014-06-24 |
2016-08-23 |
Sydnexis, Inc. |
Ophthalmic composition
|
WO2016172712A2
(en)
|
2015-04-23 |
2016-10-27 |
Sydnexis, Inc. |
Ophthalmic composition
|
CN106794144B
(zh)
|
2014-07-03 |
2020-07-17 |
奥德纳米有限公司 |
环丙沙星组合物的灭菌
|
US10500303B2
(en)
|
2014-08-15 |
2019-12-10 |
Tepha, Inc. |
Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
|
US11382909B2
(en)
|
2014-09-05 |
2022-07-12 |
Sydnexis, Inc. |
Ophthalmic composition
|
WO2016044683A1
(en)
|
2014-09-19 |
2016-03-24 |
Tensive Controls, Inc. |
Anti-microbial peptides
|
WO2016057796A1
(en)
|
2014-10-08 |
2016-04-14 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Flowable electronics
|
US20160106804A1
(en)
|
2014-10-15 |
2016-04-21 |
Yuhua Li |
Pharmaceutical composition with improved stability
|
WO2016065245A1
(en)
|
2014-10-24 |
2016-04-28 |
Incept, Llc |
Extra luminal scaffold
|
CA3015557C
(en)
|
2014-11-07 |
2019-07-16 |
Indivior Uk Limited |
The use of sustained-release buprenorphine formulations for the treatment of pain or opioid use disorders
|
AU2015360469B2
(en)
|
2014-12-10 |
2021-03-25 |
Incept, Llc |
Hydrogel drug delivery implants
|
EP3230500A1
(de)
|
2014-12-11 |
2017-10-18 |
Tepha, Inc. |
Verfahren zur ausrichtung von multifilamentgarn und monofilamenten aus poly-4-hydroxybutyrat und copolymere davon
|
US10626521B2
(en)
|
2014-12-11 |
2020-04-21 |
Tepha, Inc. |
Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
|
US11382731B2
(en)
|
2015-02-27 |
2022-07-12 |
Covidien Lp |
Medical devices with sealing properties
|
WO2016168388A2
(en)
|
2015-04-14 |
2016-10-20 |
Palatin Technologies, Inc. |
Therapies for obesity, diabetes and related indications
|
AU2016261925B2
(en)
|
2015-05-12 |
2020-10-01 |
Incept, Llc |
Drug delivery from hydrogels
|
CN107847432A
(zh)
|
2015-05-29 |
2018-03-27 |
西德奈克西斯公司 |
D2o稳定化的药物制剂
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
EP3328898B8
(de)
|
2015-07-28 |
2024-04-10 |
6452728 Canada Corp. |
Trkb- oder trkc-agonisten-zusammensetzungen und verfahren zur behandlung von erkrankungen des ohrs
|
HUE052832T2
(hu)
|
2015-08-03 |
2021-05-28 |
Tolmar International Ltd |
Folyékony polimer leadó rendszer gyógyszerek nyújtott adagolására
|
HRP20231453T1
(hr)
|
2015-11-16 |
2024-03-01 |
Medincell S.A. |
Postupak za morseliranje i/ili usmjeravanje farmaceutski aktivnih sastojaka na sinovijalno tkivo
|
WO2017084973A1
(en)
|
2015-11-16 |
2017-05-26 |
Evonik Röhm Gmbh |
Injection solution comprising a non-nucleoside reverse-transcriptase inhibitor and poly(lactide-co-glycolide)
|
CN108601725B
(zh)
|
2015-11-25 |
2024-03-08 |
因赛普特有限责任公司 |
形状改变的药物递送装置和方法
|
WO2017100576A1
(en)
|
2015-12-11 |
2017-06-15 |
Otonomy, Inc. |
Ciprofloxacin otic composition and kits and method for using same
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
WO2017173071A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
WO2017210109A1
(en)
|
2016-06-03 |
2017-12-07 |
Lifecell Corporation |
Methods for localized modification of tissue products
|
DK3503877T3
(en)
|
2016-08-26 |
2022-05-23 |
Sk Joint Ventures Ii Llc |
Biodegradable polymer formulations for extended efficacy of botulinum toxin
|
EP3512513A4
(de)
|
2016-09-16 |
2020-04-15 |
Otonomy, Inc. |
Gelformulierungen für das ohr zur behandlung von otitis externa
|
US11439587B2
(en)
|
2016-09-22 |
2022-09-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Injectable implants
|
EP4197527A1
(de)
|
2016-09-23 |
2023-06-21 |
Incept, LLC |
Intrakamerale wirkstofffreisetzungsdepots
|
US11072642B2
(en)
|
2016-11-09 |
2021-07-27 |
Mayo Foundation For Medical Education And Research |
MANP analogues
|
EP3551110A4
(de)
*
|
2016-12-12 |
2020-06-03 |
Neuronoff, Inc. |
Auf die konturen eines ziels in körpergewebe härtbare und formbare elektrode und verfahren zur herstellung und platzierung sowie spender dafür
|
JP2020501660A
(ja)
|
2016-12-22 |
2020-01-23 |
ライフセル コーポレーションLifeCell Corporation |
組織を凍結切削する装置および方法
|
LT3576771T
(lt)
|
2017-01-31 |
2022-04-11 |
Veru Inc. |
Kompozicijos ir būdai, skirti gonadotropiną atpalaiduojančio hormono (gnrh) antagonistų ilgalaikiam atpalaidavimui
|
US10646484B2
(en)
|
2017-06-16 |
2020-05-12 |
Indivior Uk Limited |
Methods to treat opioid use disorder
|
US20200276209A1
(en)
|
2017-09-11 |
2020-09-03 |
Sage Therapeutics, Inc. |
Methods of treating epilepsy or status epilepticus
|
JP7297739B2
(ja)
|
2017-10-18 |
2023-06-26 |
ライフセル コーポレーション |
脂肪組織製品および製造方法
|
US11123375B2
(en)
|
2017-10-18 |
2021-09-21 |
Lifecell Corporation |
Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
|
US11246994B2
(en)
|
2017-10-19 |
2022-02-15 |
Lifecell Corporation |
Methods for introduction of flowable acellular tissue matrix products into a hand
|
WO2019079672A1
(en)
|
2017-10-19 |
2019-04-25 |
Lifecell Corporation |
ACELLULAR TISSUE MATRIX PRODUCTS FLUIDS AND METHODS OF PRODUCTION
|
EP3700465A4
(de)
*
|
2017-10-23 |
2021-08-18 |
Endologix LLC |
Endoluminale vorrichtung und polymer
|
US11717555B2
(en)
|
2017-12-18 |
2023-08-08 |
Foresee Pharmaceuticals Co., Ltd. |
Pharmaceutical compositions having a selected release duration
|
WO2019154895A1
(en)
|
2018-02-08 |
2019-08-15 |
Strekin Ag |
Gel formulation for preventing or treating hearing loss
|
MX2021000238A
(es)
|
2018-07-09 |
2021-05-12 |
Regeneron Pharma |
Ajuste de las cinéticas de liberación en hidrogeles.
|
UY38386A
(es)
|
2018-09-25 |
2020-04-30 |
Tolmar Int Ltd |
Sistema de suministro de polímero líquido para la administración prolongada de fármacos
|
EP3946547A4
(de)
|
2019-03-26 |
2023-01-18 |
Pocket Naloxone Corp. |
Vorrichtungen und verfahren zur abgabe von pharmazeutischen zusammensetzungen
|
US20220265760A1
(en)
|
2019-05-27 |
2022-08-25 |
Tolmar International Limited |
Leuprolide acetate compositions and methods of using the same to treat breast cancer
|
CA3142151A1
(en)
|
2019-05-30 |
2020-12-03 |
Lifecell Corporation |
Biologic breast implant
|
KR20220036946A
(ko)
|
2019-06-27 |
2022-03-23 |
레이어바이오 인크. |
안구 장치 전달 방법 및 시스템
|
GB201910895D0
(en)
*
|
2019-07-31 |
2019-09-11 |
Univ Birmingham |
Curable monomers and compositions
|
WO2021043771A1
(en)
|
2019-09-02 |
2021-03-11 |
Camurus Ab |
Formulations and treatment methods
|
CA3154134A1
(en)
|
2019-09-30 |
2021-04-08 |
Tolmar International Limited |
Liquid polymer compositions and systems for extended delivery of peptides as active pharmaceutical ingredients
|
US20240082151A1
(en)
|
2019-10-07 |
2024-03-14 |
Oak Crest Institute Of Science |
Orally implantable drug delivery device
|
WO2021108722A1
(en)
|
2019-11-27 |
2021-06-03 |
Oak Crest Institute Of Science |
Sustained release drug delivery device
|
CA3167217A1
(en)
|
2020-01-13 |
2021-07-22 |
Durect Corporation |
Sustained release drug delivery systems with reduced impurities and related methods
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
US11278709B1
(en)
|
2021-03-12 |
2022-03-22 |
Pocket Naloxone Corp. |
Drug delivery device and methods for using same
|
CA3218153A1
(en)
*
|
2021-06-30 |
2023-01-05 |
Soumya Rahima BENHABBOUR |
Injectable, biodegradable and removable polymer based drug suspension for ultra-long-acting drug delivery
|
WO2023046731A1
(en)
|
2021-09-21 |
2023-03-30 |
Laboratorios Farmacéuticos Rovi, S.A. |
Antipsychotic injectable extended-release composition
|
CN114404659B
(zh)
*
|
2021-12-06 |
2022-09-16 |
中国科学院长春应用化学研究所 |
一种管状材料、其制备方法及其应用
|
WO2023133517A1
(en)
|
2022-01-06 |
2023-07-13 |
Oak Crest Institute Of Science |
Subdermal implant for sustained drug delivery
|
WO2024003291A1
(en)
|
2022-06-30 |
2024-01-04 |
Virbac |
Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction
|